foods

Review
Sources, Extraction and Biomedical Properties
of Polysaccharides
Samee Ullah 1,2 , Anees Ahmed Khalil 2 , Faryal Shaukat 1 and Yuanda Song 1, *
1 Colin Ratledge Center for Microbial Lipids, Center for Functional Foods and Health, School of Agriculture
Engineering and Food Science, Shandong University of Technology, Zibo 255049, China
2 University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences,
The University of Lahore, Lahore 54000, Pakistan
* Correspondence: [email protected]; Tel.: +86-139-0617-4047




Received: 16 July 2019; Accepted: 28 July 2019; Published: 1 August 2019


Abstract: In the recent era, bioactive compounds from plants have received great attention because of
their vital health-related activities, such as antimicrobial activity, antioxidant activity, anticoagulant
activity, anti-diabetic activity, UV protection, antiviral activity, hypoglycemia, etc. Previous studies
have already shown that polysaccharides found in plants are not likely to be toxic. Based on these
inspirational comments, most research focused on the isolation, identification, and bioactivities of
polysaccharides. A large number of biologically active polysaccharides have been isolated with
varying structural and biological activities. In this review, a comprehensive summary is provided of
the recent developments in the physical and chemical properties as well as biological activities of
polysaccharides from a number of important natural sources, such as wheat bran, orange peel, barely,
fungi, algae, lichen, etc. This review also focused on biomedical applications of polysaccharides.
The contents presented in this review will be useful as a reference for future research as well as for
the extraction and application of these bioactive polysaccharides as a therapeutic agent.

Keywords: bioactive polysaccharides; extraction; biomedical applications

1. Introduction
Polysaccharides are considered as vital bio-macromolecules for all living organisms, which
are structurally comprised of homo or hetero monosaccharides and uronic acids connected with
glycosidic linkages [1–3]. They are predominantly found in various parts of plants, animals, fungi,
bacteria, and seaweed, and play a critical role in numerous physiological functions of life [4].
Polysaccharides along with lipids, proteins, and polynucleotides are classified as the most pivotal four
macromolecules in life sciences. Bioactive polysaccharides are known as polysaccharides produced
from living organisms, and/or are functionalized from sugar-based materials possessing biological
effects on organisms. Moreover, during the last decades, bioactive polysaccharides have been
investigated as therapeutic agents against many chronic diseases due to their biodegradability,
non-toxic nature, and biocompatibility [5]. Studies have shown that polysaccharides possess a wide
range of pharmacological perspectives such as antioxidative, antitumor, antimicrobial, anti-obesity,
hypolipidemic, antidiabetic, and hepato-protective properties [6–8]. They have been investigated
extensively for the development of novel products in the field of cosmetics, food, medicine,
petrochemicals, and paper [3,9,10]. Particularly, in the medicinal industry, polysaccharides are mostly
used as pharmaceuticals and medical biomaterials (hypoglycemic, anti-osteoarthritic, and anticancer
products) to curtail the effect of respective metabolic syndromes [9,11].
The potentiality of bioactive polysaccharides is strongly influenced depending upon their
configuration and chemical structure. Nevertheless, the macromolecular configurations of plant

Foods 2019, 8, 304; doi:10.3390/foods8080304 www.mdpi.com/journal/foods

Foods 2019, 8, 304 2 of 23

cellular polysaccharides, particularly hetero polysaccharides (hemicelluloses), are very complex owing
to the occurrence of various monosaccharides acting as isobaric stereoisomers [12,13]. Additionally,
polysaccharides present in plants, microorganisms (bacteria, fungi, and yeasts), animals, and algae
are chemically and/or physically bound with various other biomolecules like lignin, proteins,
lipids, polynucleotides, and a few minerals [14]. Hence, to understand the importance of bioactive
polysaccharides in the domain of life sciences resulted in the multi-disciplinary collaboration
of scientists from the fields of microbiology, phytology, glycol-biology, nutrition, food sciences,
and glycol-medicine [5]. Polysaccharides both in the simple and complex glycol-conjugated form are
renowned for various bioactive functions, for instance, antivirus, antioxidant, antimicrobial, anticancer,
antidiabetic, reno-protective, immunomodulatory, and anti-stress perspectives.

2. Sources of Bioactive Polysaccharides

Bioactive polysaccharides are categorized broadly depending upon their sources, structure,
applications, solubility, and chemical composition. On the basis of chemical composition, they are
characterized as homopolysaccharides (homoglycans) and heteropolysaccharides (heteroglycans).
Homoglycans comprise of a single type of monosaccharide, such as glycogen and cellulose which
consists of glucose molecules, whereas heteroglycans are made up of a different type of monosaccharides,
for example, heparin and chondroitin sulfate (CS) [15].
According to the glycosides linked on to the glycan, polysaccharides can also be classified as
proteoglycans and glycoproteins, glycolipids, and glycoconjugates [16,17]. According to grouping
based on origins, bioactive polysaccharides are usually classified as those derived from animals
(chondroitin sulfate, heparin, and hyaluronan), plants (pectin, inulin, Ginseng polysaccharides, xylans,
and arabinans), bacteria (exopolysaccharides, capsular polysaccharides, and peptidoglycans), lichen,
fungi, and algae. In the section below, bioactive properties associated with polysaccharides are
reviewed depending upon their natural sources in order to understand their functionality.

2.1. Bioactive Polysaccharides in Dietary Fibers

The FAO (Food and Agriculture Organization) defined dietary fibers as a variety of indigestible
plant polysaccharides including pectins, cellulose, gums, hemicelluloses, oligosaccharides, and various
lignified compounds. Dietary fibers are the type of polysaccharides that are biologically active in their
innate form and/or after enzymatic and chemical treatments. For instance, celluloses and hemicelluloses
directly stimulate the bowel movement, whereas inulin is fermented by microflora with the intent
to prevent various gastrointestinal disorders [18]. Dietary fibers play a vital role in prevention from
various diseases especially hyperlipidemia, cardiovascular complications, and obesity. Gums, inulin,
and pectin are capable of slowing down the passage of food in the digestive tract, reducing serum
cholesterol concentrations, hindering the absorption of sugar from food to bloodstream and, therefore,
avoiding sudden hyperglycemic conditions post food ingestion.
Among dietary fibers, lignin, cellulose, and hemicellulose are classified as insoluble fibers which
help in the stimulation of the bowel movement, speeds up the removal of waste via the digestive
tract, and helps in prevention of hemorrhoids, constipation, and diverticulosis [19,20]. Results of
various epidemiological investigations and clinical trials have suggested that consumption of moderate
or higher levels of dietary fiber efficiently reduces the risk of numerous metabolic syndromes like
diabetes [21], strokes [22], hypertension [23,24], hyperlipidemia/hypercholesterolemia, [25,26], obesity,
and cancer [27]. Usually, ingestion of dietary fiber has health modulating benefits, like increased stool
bulk, reduced intestinal transit time, a decline in levels of total cholesterol (TC) and postprandial
blood glucose, and/or insulin contents [27–29]. Keeping in view the significance of dietary fibers with
special reference to human health and their associated mechanism of actions, these are considered
as an abundant source of bioactive polysaccharides. Table 1 summarizes the types, names, sources,
composition, and physiological effects of dietary fiber polysaccharides from various studies and trials.
Foods 2019, 8, 304 3 of 23

2.2. Bioactive Polysaccharides in Herbs

Herbs have attained a significant position in traditional medicines (Indian Ayurveda, ancient
Chinese medicine, phytomedicine in western countries, and Japanese Kamp medicine) of numerous
countries owing to their associated curing benefits against numerous diseases. Outcomes of
recent pharmacological studies have illuminated that the chief component of herbal medicines
usually comprises of tannins, polysaccharides, high molar mass proteins, and low molar mass
constituents like terpenoids (quassinoids, sesquiterpenes, and Rabdosia diterpenes), saponins, alkaloids
(protoberberine alkaloid, phenanthridine, etc.), and flavonoids (Scutellaria flavones) [30]. Among
the above-mentioned compounds in herbal medicines, polysaccharides are believed to be main
bioactive compounds responsible for various pharmacological potentials like antitumor, antioxidant,
hepato-protective, antiviral, radio-protective, immuno-stimulatory, and anti-fatigue activities [31–35].
Innate polysaccharides present in numerous herbs are known for stimulation of the human
immune system, inhibition of viral replication, scavenging free radicals, and inhibition of lipid
peroxidation [33,36,37]. Recent advancements regarding the application of polysaccharides present in
herbal medicines for prevention and cure of diseases are documented in Table 1.

Table 1. Biological activities of bioactive polysaccharides.

Polysaccharides Biological Activities Mechanism of Action References

• Reduced energy intake
β-glucan Anti-obesity activity • Increase in fullness and satiety [38]
• Decreased hunger and increased satiety and fullness.
• Inhibitory effects on the entry of enveloped viruses
Pectin, Algal Anti-microbial
including herpes and HIV into cells [39,40]
Fucoidan activity
• Inhibit the formation of syncytium formation
Fucoidan, • Inhibited ERK and p38-MAPK signaling pathways
Polygonum scavenging free radicals (e.g., superoxide anion radical,
multiflorum Anti-oxidant activity hydroxyl radical, and hydroxyl peroxide), [40,41]
Thunb • Prevents lipid oxidation and protein glycation
Polysaccharides • Inhibits the formation of ROS and RNS
• Lowered the expression of inducible nitric oxide
Red algae sulfated synthase (iNOS)
polysaccharides,
Anti-inflammatory • Inhibited the expressions of TNF-a, interleukin-1b (IL-1b)
Carrageenan, [40,42,43]
activity and interferon-c (IFN-c)
Fucoidan,
Chondroitin sulfate • Repressed pro-inflammatory cytokines
• Suppresses the activity of COX-2
• Suppressed the formation of AGE
β-glucan Anti-diabetic activity • Reduced postprandial glucose and insulin responses [38]
• Increases the level of antioxidant enzymes in the body
• Reduced the plasma cholesterol
Hypo-cholesterolemic
Konjac glucomannan • Significantly lowered Serum total, HDL-C, and LDL-C [44]
activity
• Reduces the concentration of serum MDA
• Constrains the production of prostaglandin E2
• Prevents from the oxidation of DNA
Pectin, Ginseng
• Stimulates macrophages to produce helper types 1 and 2
polysaccharides, Anti-tumour activity [39,45,46]
(Th1 and Th2) cytokines
Heparan sulfate
• Promotes the formation of ternary complexes
• Displaces growth factors
• Downregulates the secretion of inflammation related
Ginseng Immune modulatory mediator nitric oxide (NO) and cytokines (TNF-a, IL-6,
[45]
polysaccharides activity and IL-1b)
• Reduces the activation of neutrophils
β-glucan, Pectin,
Gastro-protective • Supplement increased faecal bulk
Gums, Konjac [19,44]
activity • Alter postprandial lipid and lipoprotein composition
glucomannan
• Increase SOD and GSH-Px activities and IL-10 levels
Acanthopanax Neuro-protective
• Reduces the levels of MDA, IL-1, and TNF-α [47]
polysaccharides activity
• Prevents the formation of inflammatory cytokines
Foods 2019, 8, 304 4 of 23

2.3. Bioactive Polysaccharides in Algae and Lichens

Polysaccharides present in lichens and algae have been of great interest to the food scientists
owing to their associated exceptional physical properties (stabilizing, gelling, and thickening capability)
and biological potentials (immunomodulating, antiviral, anticoagulant, antitumor, antioxidative,
anti-inflammatory, and anti-thrombotic activity) [48,49]. Basically, sulfated polysaccharides are the
main group of the most attractive and interesting constituents in marine algae i.e., laminarans and
fucoidans in the Phaeophyceae (brown algae), carrageenans in the Rhodophyceae (red algae), and
ulvans in the Chlorophyceae (green algae) [40]. One of the most vital properties linked with sulfated
polysaccharides is their anticoagulant characteristics. For instance, carrageenan (sulfated galactans)
isolated from red algae and sulfated fucoidans extracted from brown algae are known to possess
excellent anti-coagulant properties. Sulfated polysaccharides identified in algae have been stated to
own equal or even stronger activities than those linked with heparin [32]. Various other biological
properties of sulfated polysaccharides present in algae have been intensively investigated.
Experimentally, fucoidan has been reported to possess maximum antioxidative properties
followed by alginate and laminaran, therefore protecting human health from the damage of ROS
(reactive oxygen species). Likewise, the anticancer and anti-tumor characteristics of algae-based
sulfated polysaccharides are found to be due to their antioxidative and free radical scavenging
properties [50]. Moreover, inhibition of HIV and herpes viruses in cells owing to anti-viral potential of
sulfated rhamnogalactans, carrageenans, and fucoidans have also been scientifically proven [40].
Immuno-modulating characteristics associated with algae-based sulfated polysaccharides were
demonstrated by increasing the secreting and phagocytic activities of macrophages [51].
Polysaccharides derived from lichens (composite organism formed due to a symbiotic partnership
among alga and fungus) are principally linear or rarely substituted α-glucans and/or β-glucans.
This type of glucans isolated from lichens is reported to have a wide range of bioactive functions
such as immunomodulatory perspectives, anti-tumor potential, and anti-viral characteristics [49,52,53].
The immuno-modulating activity of polysaccharides (β-glucans) derived from lichenin and lichens
are linked to stimulation of a variety of immune responses like production of NO (nitric oxide) and
ROS (reactive oxygen species) and release of cytokines and arachidonic acid metabolites [51]. Lichenin,
also known as lichenan, consists of a galactoglucomannan (water-soluble hemicellulose) structure that
is responsible for anti-thrombotic and anti-coagulant properties [54]. Bioactive properties related to
sulfated polysaccharides from lichens and algae are highly dependent on their structural properties,
for instance, sulfate concentration and distribution of sulfate groups on the main chain, stereochemistry,
and molar masses. Hence, there is a need for the modification of innate sulfate polysaccharides to
attain biologically active polysaccharides having desired molecular size and functionality for bioactive
further application [40,55]. An overview of some recent advancements in this context are depicted in
Table 2.

2.4. Bioactive Polysaccharides in Fungi

A wide range of bioactive saccharides is present in fungi ranging from monosaccharides to
polysaccharides. They can be summarized as the intracellular or extracellular polysaccharides
depending upon their presence in the fungi [56]. The bioactive polysaccharides derived from
basidiomycetes are reported to have antitumor and anticancer activities and can prevent breast
cancer in post-menopausal women. The compound which can inhibit tumors was first isolated from
the basidiomycete Boletus edulis in 1957. In traditional medicine, several basidiomycete mushrooms are
used as an immunosuppressant to treat cancer and even for treating AIDS [57]. Polysaccharopeptide
(PSP) isolated from Ganoderma lucidum induces the inhibition of oncogenes and kill the tumor cells
directly. Similarly, the bioactive polysaccharides schizophyllan, lentinan, and polysaccharide-K isolated
from Grifola frondosa and Trametes versicolor, respectively, improve the immune function of the host
and showed a synergistic effect with chemotherapy [58]. Just like mushrooms, another source of
bioactive polysaccharides is Cordyceps militaris, and they possess a wide range of structurally different
Foods 2019, 8, 304 5 of 23

bioactive polysaccharides. Water-soluble polysaccharides from C. militaris contain a (1 → 4) galactose

linkage and (1 → 3,6)-mannose linkage and branching usually arising from (1 → 4)-linked glucose.
These polysaccharides were reported for their numerous biological activities including anti-tumor,
immunomodulatory, antioxidant, and anti-inflammatory activities [56,59].

2.5. Bioactive Polysaccharides from Bacteria

Bacteria are a rich source of biologically active polysaccharides. On the base of structural properties,
bacterial polysaccharides can be defined into five major classes: Exopolysaccharides (EPSs), capsular
polysaccharides (CPSs), lipopolysaccharides (LPSs), peptidoglycans, and teichoic acids [60].
A lot of research has been done on hyperbranched bacterial polysaccharides (HBPSs). For example,
highly branched dextran with a backbone of 75% (α-(1→6)-D-Glcp) with 19% of α-(1→3) and a few
α-(1→2) branching [61], was separated from Leuconostoc citreum B-2 and studied extensively, and showed
a water-holding capacity of up to 450% and an 80% water solubility index, consequently having
potential applications in cosmetic, food, and pharmaceutical industries [62,63]. From an industrial
point of view, EPSs producing Gram-negative prokaryotes (cyanobacteria) are important because of
their ability to produce novel molecules. These EPSs usually linger as a sheath/capsule with the cells
and when they are liberated from the cells they are termed as released polysaccharides. Some bacteria
from the genus cyanobacterium, namely Anabaena, Aphanocapsa, Cyanothece, Phormidium, Synechocystis,
and Nostoc are useful to produce sulfated EPSs, which also contain uronic acids [64]. Upon fermentation
in the laboratory, polysaccharide yield from 0.5–4 g/L can be obtained from three known genera of
marine bacteria, namely Alteromonas sp., Pseudoalteromonas sp. and Vibrio sp. [65]. Exopolysaccharide
HE 800 is secreted by Vibrio diabolicus and it contains an equal amount of hexosamine and glucuronic
acid, which can be depolymerized, N-deacetylated, and after chemical sulfurylation produce new
derivatives of HE800. These derivatives are referred to as DRS HE800 and are structurally very close
to heparan-sulfate [66]. Moreover, acidic and highly branched heteropolysaccharide (EPS GY785) is
produced by the bacterium Alteromonas infernus. Non-saccharide units of EPS GY785 are composed of
uronic acid and sugar (glucose and galactose) [67].
EPSs derived in the laboratory showed widespread biological activities like being an antioxidant,
having cholesterol-lowering and inflammation-regulating properties, as well as anti-tumor, anti-
coagulant, and antivirus activities [62,68]. Moreover, bacterial polysaccharides are used in Protein
Glycan Coupling Technology (PGCT) to produce glycoconjugate vaccines against Gram-positive and
Gram-negative bacteria [69].

2.6. Bioactive Polysaccharides in Wood

Bioactive polysaccharides present in wood primarily consists of celluloses and some primary
groups of hemicelluloses (glucans, arabinans, xylans, glucomannans, and galactans) [70,71]. Pectins
and galacto-glucomannans derived from wood are stated to have radical scavenging properties and
immune-stimulating activities [72,73]. Xylo-oligosaccharides (xylans) derived from dietary fibers,
hard and/or softwood have been reported to be used efficiently as prebiotics by nutraceutical and
medicinal industries [74]. Similarly, pentosane polysulfate—a xylan derivative being extracted
from beech-wood—is also known as a biomedical agent for the treatment of interstitial cystitis,
a bladder pain syndrome [75]. While most polysaccharides do not reveal biological properties
unless they are subjected to some modification; derivatives of cellulose-like hydroxypropyl-cellulose
(HPC), hydroxypropyl-methylcellulose (HPMC), hydroxyethyl-cellulose (HEC), and methyl-cellulose
have evidently proven their functional roles in numerous fields (medicinal, cosmetics, food,
and pharmaceutical) [76].

2.7. Bioactive Polysaccharides from other Sources

Sulfated glycosaminoglycans (GAGs) like keratin sulfate (KS), heparan sulfate (HS), dermatan
sulfate (DS), and chondroitin sulfate (CS) belongs to a class known as animal-derived bioactive
Foods 2019, 8, 304 6 of 23

polysaccharides. Heparan sulfate comprises of repeated units of N-acetylated and sulfated disaccharides
(glucosamine and glucuronic/iduronic acid) units [77–79]. Evidently, heparin is known to be the
most effectual clinical anti-coagulant used in medical sciences. The anti-coagulation potential of
heparin is mainly due to its particular structural arrangement, in which specifically the binding
site of anti-thrombin III (ATIII, a non-vitamin K-dependent protease) is of central importance in the
prevention of fibrin clot formation which is generated owing to the enzymatic activity of thrombin [80].
Better knowledge regarding the interlinkage among structural properties and activity of heparin
creates an opportunity for the development of new drugs having more specificity and improved
anti-coagulating properties. Furthermore, this structural-activity connection is also helpful in exploring
various biomedical applications like anti-viral, anti-inflammatory, anti-cancer, and wound healing
properties [78,79,81,82]. DS and CS chains comprise of sulfated N-acetylgalactosamine and iduronic
acid (in case of DS)/glucuronic acid (in case of CS) disaccharide repeating units [83,84]. Both of these are
functionally characterized as bioactive polysaccharides owing to their presence as a vital molecule in the
extracellular matrix of the brain, which helps in regulation of cell migration, adhesion, and proliferation
while healing of wounds, as well as proper signaling of growth factor in the skeleton [85–88].
On the other hand, HA (hyaluronic acid) primarily isolated form animal tissues comprise
of the linear structure of non-sulfated glycosaminoglycan molecules with repeated units of
β-(1-3)-N-acetyl-d-glucosamine, and β-(1-4)-d-glucuronic acid. It is also a vital constituent of the brain’s
extracellular matrix, which promotes mediation of cellular signaling, helps in healing of wounds, and
morphogenesis. Owing to these properties, HA and their associated derivatives are predominantly
being applied by the medical industry in eye surgery, viscosupplementation, and as a biomedical tool
for drug delivery [89–91]. Chitin is known to be the most abundant polysaccharide present in the
exoskeleton of shrimps and crabs, the cell walls of yeast and fungi, and the cuticles of insects. It is
by far the second most copious polymer after cellulose and comprises of a random distribution of
β-(1-4)-linked N-acetyl-glucosamine and N-glucosamine [92,93]. Industrially, chitosan is characterized
as a vital derivative of chitin and is practically obtained due to partial deacetylation of chitin either
by the action of enzyme chitin deacetylase or under alkaline conditions [94]. Bioactive properties
(anti-cancer, anti-tumor, anti-bacterial, anti-inflammatory, etc.) associated with oligomers of chitosan
and chitin, yielded owing to partial acidic hydrolysis, have earlier been documented [95].

3. Extraction and Quantification of Bioactive Polysaccharides

In general, bioactive potentials of naturally occurring polysaccharides are greatly dependent
upon their molar mass and level and distribution of groups/side chains on the backbone. Therefore,
isolation of polysaccharides from complex cellular plant matrices while keeping their bioactivity
intact is of great significance. During the last decade, various innovative green extraction techniques
(microwave-assisted, ultra-sonication, supercritical fluid extraction, and hot water extraction) are in
practice for isolation of bioactive polysaccharides. These techniques have acquired great attention
of scientists and researchers mainly due to their increased extraction rates, cost-effective nature,
enviro-friendly characteristics, and structure preservative potentials [73,96,97].
Numerous scientific investigations have been implemented for the extraction and isolation of
bioactive polysaccharides. The type of method adopted defines the physicochemical properties
and antioxidant potential of isolated polysaccharides. For this purpose, a group of scientists
compared the structural and antioxidant properties of bioactive polysaccharides extracted from
Barrenwort (Epimedium acuminatum) through various extraction techniques (microwave-assisted,
enzymatic, hot water extraction, and ultrasound-assisted extraction). They were of the view that
bioactive polysaccharides isolated from hot water extraction had the highest antioxidant properties
as compared to those extracted from other techniques, while their physicochemical properties were
the same [98]. The hot water extraction method used in combination with various latest techniques
(enzymatic pre-treatment, microwave, and ultrasound-assisted) are useful in increasing the yield and
extraction productivity of polysaccharides. Likewise, enzymatic pre-treatment of raw material prior to
Foods 2019, 8, 304 7 of 23

extraction resulted in reduced extraction time, minimized the use of extraction solvents, preserved the
bioactivities of the polysaccharides, and was energy efficient as compared to non-enzymatic pre-treated
techniques [99]. In recent times, various ionic liquids have been formulated which aids in extraction of
polysaccharides in a shorter time and at lower temperatures [100].

Table 2. Extraction techniques with reference to specific polysaccharides.

Type Name Sources Extraction Techniques Quantity/Yield References

Acid Hydrolysis 32.8%
Cellulose Coconut fibre [101]
Ammonium persulphate
49.6%
oxidation
Ultrasound extraction 88.1%
Alkaline extraction 33.32%–64.1%
Hemicelluloses Wheat bran [102]
Hydrothermal extraction 9% (14)
Microwave-assisted extraction 24.2%
[103]
Pectins Orange peels Conventional extraction 18.32%
Dietary Ultrasound extraction 19.24%
fibres
Barley 4.6%
Acidic extraction
Oats 6.97%
Barley bran 5.6%–11.9%
Oat bran Alkaline extraction 3.9%–8.0%
B-glucan [104]
Wheat bran 2.15%–2.51%
Barley 3.94%
Barley 2.5%–5.4%
Water extraction
Oat 2.1%–3.9%
Barley 5.22%
Enzymatic extraction
Oat 13.9%
Gums Durian fruit Aqueous extraction 59.7% [105]
Water extraction using
Amorphophallus konjac 59.02%
Konjac glucomannan Al2(SO4 )3 [106]
plant
Ethanol extraction 65.23%
Subcritical water extraction 63.1%
Ginseng
Panax ginseng roots [107]
polysaccharides Water extraction 14.71%
Ethanol extraction 17.96%
Water extraction 11.6% (20)
Herbs Astragalus Microwave-assisted extraction 16.07% [108]
Astragalus roots
polysaccharides
Ultrasound-assisted extraction 24.12%
Enzymatic hydrolysis extraction 9.78%

Polygonum multiflorum 2.90%–4.72%

Polygonum multiflorum Ultrasound-assisted extraction [109]
Thunb (21)
Thunb root
Polysaccharides Ethanolic extraction 4.9% (22) [110]
Green algae sulfated Green algae, Soxhlet extraction 10%–20% (23) [111]
polysaccharides Caulerpa racemosa
Ultrasound assisted extraction 8.3% (24) [112]
Red algae sulfated
Red algae, Porphyra
polysaccharides Ultrasound-assisted extraction 6.24% (25) [113]
Algae and haitanensis
(porphyran)
lichens
Green algae sulfated Green algae, Hot water extraction 15.9%
[114]
Rhamnan Monostroma latissimum Microwave-assisted extraction 53.1% (26)
Aqueous extraction 53.33%
Brown algae, [115]
Algal Fucoidan Enzymatic extraction 57.00% (27)
Ecklonia cava
Microwave assisted extraction 18.22% (30) [116]
β-Glucans Lichenan Cetraria islandica Hot water extraction 50.9%
[117]
lichenan Pustulan Lasallia pustulata Hot water extraction 38%
Monosaccharides and Cordyceps militaris, Hot water, alkali, and acidic
Fungi 6.36%–24.30% [56,118]
polysaccharides Dictyophora spp. solutions
Foods 2019, 8, 304 8 of 23

In addition, this purification of polysaccharides from the crude extract is really of great importance
as the linkage among structure and safety of products formed for food, pharmaceutical, and biomedical
application depends on this. Purification could be achieved by using various techniques (gel filtration,
ion exchange and affinity chromatography, ethanolic precipitation, and fractional precipitation),
individually or in combination [32].

4. Biomedical Applications
Polysaccharides and their derived compounds are medicinally more preferred as compared
to synthetic polymers owing to their biodegradability, non-toxic nature, biocompatibility, and low
processing expenses. Mentioned benefits related to polysaccharides isolated from natural sources
make them a valuable ingredient in the fields of pharmaceuticals, nutraceuticals, food, and cosmetic
industries. At the present time, polysaccharides are been used in healthcare and disease control, while
various novel areas have also been discovered like in cancer diagnosis, inhibition, and treatment;
in drug delivery; in anti-bacterial and anti-viral perspectives; and in tissue engineering [92,119].
Therefore, this segment highlights the use of bioactive polysaccharides against various metabolic
syndromes and in the above-mentioned novel areas.

4.1. Anti-Microbial and Antiviral

Various clinical investigations have authenticated that oral administration of pectin to infants and
children significantly reduced diarrhea and other intestinal infections. This may be because of the
decreased concentration of pathogenic bacteria like Citrobacter, Salmonella, Enterobacter, Shigella, Proteus,
and Klebsiella [120]. A linear relationship has been documented among the concentration of probiotics
and intestinal health [28].
The bioactive potential of fucoidans—a sulphated polysaccharide derived from marine brown
seaweeds—have demonstrated noteworthy anti-viral potential against the cytomegalovirus, HIV, and
HSV (herpes simplex virus) [121]. Additionally, few other seaweed-extracted polysaccharides like
sulphated rhamnogalactans, carrageenans, and fucoidans have shown an inhibitory effect on viruses
(HSV and HIV). Fucoidan comprises of a large quantity of L-fucose and sulphate groups along with
fractions of galaturonic acid, xylose, mannose, and galactose. Undaria pinnatifida (marine brown alga)
contains fucoidans and have been used in bone health supplementation mainly due to stimulation
of osteoblastic cell differentiation. This sulphated polysaccharide has also been known to possess
preventing action on UV-B-induced matrix metalloproteinase-1 (MMP-1) expression by inhibiting the
ERK (extra-cellular signal regulated kinases) pathways. Therefore, it could be utilized as a functional
ingredient in dermal ointments to prevent from skin photo-aging [40].
Some of the other fractions of algae have properties of virucidal and enzyme inhibitory activity
inhibiting the formation of the syncytium. Besides, the sulfate group present is necessary for the
anti-HIV activity and potency increases with the degree of sulfation.

4.2. Anti-Tumor/Cancer
Numerous scientists have explored dietary fibers as possessing potent anti-cancer properties.
Amongst all, pectin has been investigated to reduce cancerous cell migration and tumor growth in
a rat model that were administrated with modified citrus pectin [122]. This may be due to binding
of pectin to galectin-3, which results in inhibitory action on some of its functional activities [123].
Anti-tumor mode of actions associated with dietary pectin are related to their immune-potentiation,
probiotic properties, tumor growth inhibition, anti-mutagenic potential, and regulatory action of
transformation-related oncogenes [124,125]. Anti-tumor mechanisms associated with pectin could be
due to cellular immunological potential [126].
According to a study, ginseng polysaccharides were found to have a stimulating effect on DCs
(dendritic cells) causing an elevated formation of IFN-g (interferon-g) [127]. It has also been documented
that acidic ginseng polysaccharides (GPs) enhanced the production of cytotoxic cells against tumors
Foods 2019, 8, 304 9 of 23

and promoted macrophages for the production of Th1 and Th2 (helper type 1 and 2) cytokines [128,129].
Depending upon disease environment or timing of treatments, ginseng polysaccharides extracted from
Panax ginseng demonstrated immuno-modulating perspectives mainly in an immunosuppressing or
immuno-stimulating manner [130]. Acidic GP also revealed modulating action on the concentrations
of antioxidative enzymes like GPx (glutathione peroxidase) and SOD (superoxide dismutase) probably
due to induction of regulating cytokines [131,132]. Likewise, Lemmon et al. [132] found that the
immuno-stimulating potential of acidic GPs isolated from American ginseng (Panax quinquefolius) was
actually mediated by polysaccharides having molecular weight more than 100 kDa [34].
Furthermore, scientists have proven the fact that heparin administration may also have a beneficial
impact on cancer and inflammation. Anti-cancerous, anti-inflammatory, and anti-tumor properties
associated with heparin and its low molecular weight species are owing to the pathological functions of
heparan sulfate (HS) chains of proteoglycan structure (HSPGs). Outcomes of an investigation validated
that heparin transfers GRs (growth factors) stored by HS chains of HSPGs in the ECM (extracellular
matrix) and on cell surfaces. Full-size heparin has potent pro-angiogenic properties as it increases the
production of ternary complexes of heparin bound FGF2 and VEGF with GF receptors [45].

4.3. Anti-Obesity and Hypocholesterolemia

Numerous trials have shown a direct relationship between consumption of dietary fiber, rich
diet/dietary fiber supplementation, and weight loss [133–137]. According to a meta-analysis comprising
of 22 clinical trials, it was documented that a 12 g increase in the content of daily fiber intake resulted
in a 10% decrease in energy intake along with a 1900 g decline in body weight [138]. More precisely,
the administration of glucomannan (1.24 g/day) along with energy-restricted diet for five consecutive
weeks caused a significant decrease in body weight as compared to the placebo group [139].
In a clinical trial on healthy volunteers, a drink containing oat β-glucan (10.5 g/400 g and 2.5 and
5 g/300 g) enhanced fullness sensation as compared to fiber-free drink [140,141]. Likewise, in healthy
adolescents subjected to biscuits enriched with barley β-glucan (5.2%) helped in suppressing appetite
ratings as compared to control biscuits [142]. Similarly, administration of bread formulated by barley
β-glucan (3%) to volunteers resulted in decrease of hunger and increased satiety and fullness. This also
resulted in a noteworthy decrease in energy intake at successive lunches [143]. On the other hand, a
bar prepared from barley β-glucan (1.2 g) subjected to healthy volunteers did not change scores for
energy intake and appetite scores as compared to control bars [144]. Effects of β-glucan on satiety
depends upon the concentration, molecular weight (31–3100 kDa), solubility, and food carrying it [38].
Furthermore, a group of scientists investigated the hypocholesterolemic perspectives of a
dietary supplement comprising equal content of konjac glucomannan (KGM) and chitosan [145].
The concentration of serum total cholesterol and low-density lipoprotein cholesterol (LDL-c)
significantly reduced at the end of the trial (28th day). Fecal excretion of bile acids and neutral
sterol were observed more at the commencement of the study as compared to the initiation of the study.
Similarly, Chen et al. [146] investigated the impact of KGM supplementation (3.6 g/day) on levels of
glucose and lipid biomarkers in hypercholesterolemic type-2 diabetic patients. Twenty-two diabetic
patients having increased serum cholesterol content were selected for this study. As compared to the
placebo group, KGM supplemented group showed decreased levels of LDL-c (20.7%), fasting glucose
(23.2%), serum cholesterol (11.1%), and Apo-B (12.9%). Fecal bile acid and neutral sterol content were
elevated significantly by 75.4% and 18.0%, respectively. Results of all the mentioned trials revealed
that KGM supplementation could assist in the treatment of hypercholesterolemic diabetic patients [44].

4.4. Anti-Diabetic
Scientific evidences have shown that β-glucan can contribute to control glycemic responses.
Numerous factors are found to affect such interactions like the nature of the food, concentration, and
molecular weight of β-glucan. Among all these, the dose of β-glucan is considered to be the most
important factor in regulating the impact of fiber on glycemic responses. As compared to other fibers,
Foods 2019, 8, 304 10 of 23

a small dose of β-glucan is sufficient to reduce the insulin and postprandial glucose responses in type
2 diabetic [147,148], healthy [149,150], and hyperlipidemic subjects [151]. Studies have revealed that
consumption of breakfasts comprising of 4, 6, and 8.6 g of β-glucan momentously reduced the mean
concentration of serum insulin and glucose as compared to control non-insulin-dependent diabetic
mellitus subjects [147]. The content of exogenous glucose was noticed as 18% less in a polenta meal
containing oat β-glucan (5 g) as compared to a control polenta meal without oat β-glucan-subjected
individuals [152]. Likewise, consumption of a meal consisting of 13C-labelled glucose and β-glucan
(8.9 g), for a period of three days, reduced (21%) the levels of exogenous 13C-glucose in plasma as
compared to control meal having no β-glucan [38,153].

4.5. Gastro-Protective
An experimental trial conducted by means of two diverse types of resistant starches (one a
high amylose granular resistant corn starch and the other was high amylose non-granular, dispersed,
and retrograded resistant corn starch) to evaluate the influence on blood lipid concentration, fecal
SCFA and bulking, and glycemic indexes. This study also comprised of supplements containing low
fiber control and high fiber control. Outcomes of this trial revealed that high fiber control (wheat bran)
and both resistance starches subjected groups showed an elevation in the fecal bulk as compared to the
low fiber control group. Likewise, the average ratio of fecal SCFAs and butyrate had progressive effects
on colon health. Xanthan gum may also be used in milk as a prebiotic for lactic acid bacteria. Similar
trials regarding prebiotics have demonstrated protective implications on the sustainability of cultures
under the presence of bile salts and refrigeration and low pH conditions. According to a study, guar
gum has the capability to change lipoprotein and postprandial lipid compositions. Supplementation of
guar gum has an influence on lipoprotein composition, lipemia, and postprandial glycaemia [19].
Chen et al. [154] explored the effect of KGM supplementation on the gastrointestinal response
in volunteer subjects. They were of the view that KGM supplementation significantly elevated the
dry and wet stool weight and defecation frequency to 21.7%, 30.2%, and 27.0%, correspondingly.
The improved dry fecal mass may be due to the existence of plant soluble materials. Nevertheless,
the bacterial biomass of total bacteria, bifido-bacteria, and lactobacilli increased in fecal mass in KGM
supplemented groups. Furthermore, reduction in fecal pH and elevation in fecal short chain fatty acids
(SCFAs) resulted in increased colonic fermentation owing to KGM supplementation [44].

4.6. Immune Modulatory

Ginseng polysaccharides (GPs) have not only been known to possess immune-stimulating
perspectives but also are found to suppress the proinflammatory responses. According to a recent
study, novel neutral polysaccharide (PPQN) derived from an American ginseng root was documented
to have a suppressing effect against inflammation. This activity was reported due to the inhibitory
effect of isolated polysaccharide on inflammatory-related mediators such as cytokines (IL-1b, IL-6,
TNF-a) and NO (nitric oxide) in comparison with LPS (lipopolysaccharide) treatment. Owing to
this mode of action, novel neutral polysaccharide isolated from an American ginseng root could be
used in modulating numerous inflammatory-related health implications (tumor, cancer, etc.) [155].
Similarly, another study reported the inhibitory influence of ginseng polysaccharides on immunological
responses noticed in collagen-induced arthritic subject [156]. P. quinquefolius (American ginseng) is
extensively used for the preparation of numerous herbal products. Extracts of P. quinquefolius were
found to suppress the immune-inflammatory response, reduced the activity of neutrophils, induced
the formation of cytokines in the spleen, and elevated the production of splenic-B lymphocytes and
bone marrow [157–160].
Platycodon grandifloras is an herbaceous plant which is used as folk medicines since ancient times
to curb various diseases like asthma, bronchitis, and pulmonary tuberculosis. Proximate composition
of P. grandifloras reveals that it is a rich source of carbohydrates (90%), protein (2.4%), ash (1.5%),
and fat (0.1%). Polysaccharides extracted from roots of P. grandifloras have been reported to possess
Foods 2019, 8, 304 11 of 23

antidiabetic, hypolipidemic and hypocholesterolemic properties [161]. Furthermore, the inulin-type

polysaccharides isolated from P. grandifloras (PGs) roots validated the immune-modulating impact on
macrophages and B-cells, but had no effect on T-cells [162].

4.7. Anti-Inflammatory
Astragalus polysaccharides (APS) are known to possess anti-inflammatory effects on cytokines of
CD4+ Th (T-helper) cells. In in-vitro antidiabetic models, an Astragalus polysaccharide has potentiated
the lowering effect on the expression of T-helper 1 (Th1) and regulated the imbalance of Th1 and Th2. APS
has reported to significantly enhance the gene expression of peroxisome-proliferator-activated receptor
gamma (PPAR-γ) in a concentration-time dependent manner [163] and stimulated superoxide dismutase
(SOD) anti-oxidative mechanism in type-1 diabetes mellitus (DM) models [164,165]. Moreover, APS
reduced the expression of iNOS (inducible nitric oxide synthase) [122]. These inflammatory markers
(NO, PPAR-γ, SOD, and iNOS) amongst diverse roles also perform numerous functions in regulating
and stimulating inflammatory response [42].
Water-soluble sulfated polysaccharides (WSSPs) isolated from marine algae are also classified as
anti-inflammatory compounds. On the other hand, very few pieces of evidence are present regarding
anti-inflammatory perspectives of seaweed based sulfated polysaccharides. In vitro and in vivo
studies have revealed that Gracilaria verrucose- and Porphyra yezoensis-derived sulfated polysaccharides
stimulated the respiratory burst and phagocytosis in experimented mouse macrophages [40]. Orally
administrated chondroitin sulfate (CS) isolated from cartilage of Skate (Raja kenojei) affected arthritic
conditions in a dose-dependent manner in chondroitin sulfate-treated groups. Pre- and post-treated
groups that were subjected to CS (1000 mg kg−1 ) revealed momentously decreased clinical scores as
compared to vehicle treated groups. CS administration decreased the infiltration of inflammatory cells
and prohibited from paw and knee joint destruction. Moreover, the results of RT-PCR showed that
CS ingestion significantly repressed the expression of IL-1b (interleukin-1b), IFN-c (interferon-c), and
TNF-α as compared to vehicle administrated group. The CS-treated group reduced the formation
of rheumatoid arthritis responses (IgG and IgM) in collagen-induced arthritic mice (CIA) model.
Outcomes of this study authenticate the shielding potential of chondroitin sulfate in CIA mice mainly
due to the inhibitory effect of pro-inflammatory cytokines formation [43].

4.8. Neuro-Protective
Acanthopanax senticosus derived polysaccharides comprised of uronic acid (22.5%), proteins (18.7%),
and carbohydrates (58.3%). It could be established that Acanthopanax-based polysaccharides may not
only help in improving symptoms regarding nervous defects but also reduced the infarct volume
and water content of the brain in rats having cerebral ischemia–reperfusion injury. Additionally,
polysaccharides isolated from A. senticosus elevated SOD, IL-10, and GSH-Px concentration and reduces
the levels of TNF-α, IL-1, and MDA in brains tissues of experimented rats. Conclusively, bioactive
polysaccharides extracted from A. senticosus protected brain damage due to antioxidative potential and
inhibitory action on stimulation of inflammatory cytokines [47].

4.9. Anti-Oxidant
Bioactive acidic polysaccharides extracted from Polygonum multiflorum showed significant
antioxidative properties (hydroxyl peroxide, superoxide anion radical, and hydroxyl radical),
protein glycation and lipid oxidation. In addition to this, the intraperitoneal (i.p.) administration
of P. multiflorium-based polysaccharides may increase the serum concentration of antioxidative
characteristics in cyclophosphamide-induced anemic mice. Results of this study validate the use
of P. multiflorium as a novel antioxidant tool to prevent oxidation [41]. Sulfated polysaccharides
not only act as dietary fiber but also act as a natural antioxidant agent. They are responsible for
the antioxidant properties possessed by marine algae. Various studies have recognized the use
of numerous classes of SPs (alginic acid, Fucoidan, and laminaran) as potent antioxidative agents.
Foods 2019, 8, 304 12 of 23

Antioxidative potential of SPs has classified by multiple in-vitro methods such as DPPH, FRAP, NO,
ABTS radical scavenging, superoxide radical scavenging assay, and the hydroxyl radical scavenging
assay. Additionally, Xue et al. [166] stated that many marine-based sulfated polysaccharides have
shown antioxidant potential in organic solvents and a phosphatidylcholine-liposomal suspension [40].

4.10. Tissue Engineering

Application of bioactive polysaccharides and their derivatives in the field of tissue engineering
(cell differentiation, cell adhesion, cell remodeling, cell proliferation, and cell responsive degradation)
has opened new horizons in medical research, and therefore impelled the researchers to regenerate new
tissues and define the structure of cellular growth [92]. Various bioactive polysaccharides including
starch, chitosan, chondroitin sulfate, alginate, cellulose, chitin, hyaluronic acid, and their derivatives are
being used as biomaterials in applications for tissue engineering [167]. Application of these bioactive
polysaccharides as scaffolds in tissue engineering are required to accomplish some requirements such
as non-toxicity, biodegradability having controlled the rate of degradation, biocompatibility, structural
integrity, and suitable porosity [92].
Chitosan and chitin have all the required potential to act as scaffolds for tissue engineering
mainly due to their mechanical strength, degradability, and immunogenicity. Hence, for tissue
engineering they are being developed as 3D-hydrogels, free standing films, porous sponges, and
fibrous scaffolds, inside which for in-vitro/in-vivo cultures the most suitable cell types are needed [168].
Designing of 3D-chitin/chitosan-based hydrogels and sponge scaffolds, and 2D-scaffolds for the
purpose of cartilage and tendon regenerations, for encapsulation of stem cells ensuring their therapeutic
application, and for utilizing these as a tool for regenerative medicine have been reported in numerous
researches [169,170]. Furthermore, for bone regeneration purpose, the tissue engineering industry
has formulated combinations of chitosan and hydroxyapatite and grafted chitosan and carbon
nanotubes [171]. Along with this, numerous other bioactive polysaccharides like cellulose, hyaluronic
acid, and starch have also been studied in detail to validate their use as a biomaterial for skin, bone,
and cartilage tissue engineering [95].

4.11. Wound Healing and Wound Dressing

Numerous bioactive polysaccharides (alginate, chitin, hyaluronan, chitosan, and cellulose) are
used for the preparation of wound healing materials owing to their intrinsic bio-compatible, less toxic,
and pharmaceutical activities [172,173]. For instance, hyaluronan is a vital extracellular component
possessing distinctive viscoelastic, hygroscopic, and rheological characteristics are well known for its
tissue repairing properties owing to their physicochemical potentials and specific interaction with
cells and extracellular matrices. It is documented earlier that hyaluronan has a multidimensional
role regarding the repairing process of cell or wound healing specifically inflammation, granulation,
formation of tissues, re-epithelialization, and remodeling. Various hyaluronan-derived products like
esterified, cross-linked, or chemically modified products are medicinally used for wound healing and
tissue repairing purposes [174]. While designing bioactive material for tissue engineering their wound
healing properties is of great interest.
Naturally available wound dressing films either prepared by encapsulation or simply dispersion
of the sodium alginate matrix in essential oils from cinnamon, lemon, tea, lemongrass, lavender,
elicriso italic, peppermint, chamomile blue, and eucalyptus have demonstrated exceptional anti-fungal
and anti-microbial activities, and therefore their application in disposable dressings for wounds
could also be found [175]. Development of wound dressings obtained from cross-linkage between
chitosan/silk fibroin blending membranes and di-aldehyde alginate have found to enhance cellular
proliferative properties, suggesting their applications as wound healing agents [176]. Preparation of
freestanding sodium alginate films or Ca2þ cross-linked alginate beads was achieved by mixing aqueous
dispersions of PVPI (povidone iodine) and Na-Alg. These films/beads showed anti-fungal/anti-bacterial
properties along with control release of povidone iodine into wounds as these products came into
Foods 2019, 8, 304 13 of 23

direct contact with the moist environment [175]. These applications validate the use of these products
therapeutically in wound dressings. Some innovative wound dressings were prepared for external
treatment of wounds by in situ injection of nanocomposite hydrogels that actually comprised of
oxidized alginate, curcumin, and N, O-carboxymethyl chitosan. Results of various in vitro, in vivo,
and histological investigations have proven the use of nanocurcumin, N, O-carboxymethyl chitosan,
and oxidized alginate-based hydrogels as novel tools in wound dressings for their application as wound
repairing agents. Furthermore, gamma radiations were successfully employed for the synthesis of silver
nanoparticles comprising of alginate and polyvinyl pyrrolidone (PvP)-based hydrogels. These products
have scientifically shown their capability regarding the prevention of fluid accumulations in exudate
wounds [177]. The amalgamation of nano-silver particles provides a promising anti-microbial property
and hence made these PvP-alginate hydrogels most appropriate for wound healing and dressing. Other
than alginate and their associated derivatives, numerous other naturally occurring polysaccharides
like hyaluronic acid, cellulose, chitosan, and chitin have been investigated by researchers to assess
their wound healing applications [178].

4.12. Drug Delivery and Controlled Release

Application of bioactive polysaccharides as a novel agent in drug delivery and controlled
release has also been studied by scientists owing to their least toxicity, minimum immunogenicity,
and biocompatibility. Various naturally occurring polysaccharide-based drug delivery systems are in
practice due to their targeted delivery/controlled release, shielding effect against premature degradation
of drugs, improvement of intracellular transportation, enhancement of bioavailability of drugs, as well
as delivery of small interfering RNA, antigens, and genes [179]. Delivery systems mentioned here
usually possess covalent/ionic cross-linkages, poly-electrolyte complexes, conjugates of polysaccharides
and drugs, and self-assembly [179]. Release of 3-D cross-linked drugs could be triggered by varying
redox potential, pH, light, ions, temperature, and application of magnetic and/or electric fields [180].
Mainly the three most abundantly used polysaccharides i.e., alginate, chitin, cellulose, and chitosan are
overviewed in detail as under in this portion.
Pharmaceutic application of cellulose and their associated derivatives could be classified either as
pharmaceutical excipients for protecting purposes or as bioactive molecules themselves. Application
of bioactive polysaccharides as pharmaceutical excipients in orally administrated drug delivery
systems have been explored to enhance the solubility and bioavailability of drugs, to increase the
final product (drug) stability, and to attain release profile from final formulations [181]. These days,
microcrystalline cellulose, rice, and corn starches have been broadly engaged in formulations of capsule
diluents, tablet dis-integrants, and glidants. Various cellulose derivatives like HPMC (hydroxypropyl
methyl cellulose), MC (methyl cellulose), HPC (hydroxypropyl cellulose), and HEC (hydroxyethyl
cellulose) possessing better physiochemical properties as compared to cellulose are evidently being
used in pharmaceutical industries [182]. For instance, HPMC phthalate has significant pH depending
solubility, specifically, stability under acidic conditions of the stomach while soluble in mild acidic
to slight alkaline solutions and, hence, are being applied for controlled release of intestinal targeted
drugs. In recent times, nanocellulose-based drug delivery systems comprising of CNCs (cellulose
nanocrystals), NFC (nanofibrillated cellulose), and BC (bacterial cellulose) have been investigated
comprehensively [183]. For example, the binding and release of the hydrochloride salt of doxorubicin
and tetracycline have been explored extensively due to ionic cross-linked systems, in which sulfate
groups on cellulose nanocrystals possessing negative charge are reversibly cross-linked ionically
to counterpart positively charged drugs. Likewise, nanofibrillated cellulose-based films have also
been investigated for entrapment of drugs and are being used in pharmaceutical industries for the
production of long-lasting drug release systems [184].
Reconnoitering the application of chitin/chitosan as bio-molecular delivery vectors have impelled
the scientists for the development of therapeutic drug delivery systems like siRNA (small interfering
RNA) carriers, antigens, and genes [185]. In vivo, therapeutic application of chitosan-based siRNA
Foods 2019, 8, 304 14 of 23

carries has shown great potential as a tool for gene expression associated diseases. Inhibitory influence
on human colorectal cancer gene expression due to the application of chitosan-siRNA nanoparticles
have been studied in an earlier study [186]. It was noticed that chitosan-siRNA nanoparticles developed
by ionic gelation with Na-tri-polyphosphate demonstrated a more targeted dene inhibiting impact
owing to increased binding and loading effectiveness. Long-lasting delivery of encapsulated antigens
or intra-dermal vaccines administrated through chitosan microneedles transdermal delivery systems
are documented to deliver more sustainable immune stimulation [187]. Though, the sensitivity of
pH could also affect the stability issues of the drug delivery systems [179]. Various other bioactive
polysaccharides like chondroitin, pectin, xanthan gum, dextran, chitin, gellan gum, chitosan, and
dextran are also being used for controlled drug delivery [1,181].

5. Conclusions
Bioactive polysaccharides have acquired significant attention from scientists as functional
biomolecules for the development of innovative and value-added products in the fields of pharmaceutics,
food, cosmetics, and the biomedical industry. Their therapeutic application is mainly due to their
bio-degradable, non-toxic, and bio-compatible nature. Extraction and isolation of naturally occurring
bioactive polysaccharides possessing high purity with maximum extraction yield, meanwhile keeping
in view that the native structure remains intact, are of great future concern and remains a field for
further exploration. Momentous results to authenticate the use of these polysaccharides as a novel tool
in the pharmaceutical and medicinal industry will require a multidimensional approach from scientists
of various fields like healthcare, food science, organic chemistry, material science and engineering,
as well as plant biology.

Author Contributions: S.U. and A.A.K. drafted this manuscript; Y.S. edited and reviewed the whole manuscript
and provided suggestions to main authors with critical input and corrections; F.S. assisted in locating and
interpreting the literature sources whenever or/and wherever was necessary; and all authors read and approved
the final manuscript.
Funding: This work was supported by the National Natural Science Foundation of China (Grant Nos. 31670064
and 31271812), and TaiShan Industrial Experts Program.
Conflicts of Interest: Authors declare no conflict of interest.

References
1. Zhang, Y.; Wang, F. Carbohydrate drugs: Current status and development prospect. Drug Discov. Ther. 2015,
9, 79–87. [CrossRef] [PubMed]
2. Li, P.; Wang, F. Polysaccharides: Candidates of promising vaccine adjuvants. Drug Discov. Ther. 2015, 9,
88–93. [CrossRef] [PubMed]
3. Do Amaral, A.E.; Petkowicz, C.L.O.; Mercê, A.L.R.; Iacomini, M.; Martinez, G.R.; Rocha, M.E.M.;
Cadena, S.M.S.C.; Noleto, G.R. Leishmanicidal activity of polysaccharides and their oxovanadium (iv/v)
complexes. Eur. J. Med. Chem. 2015, 90, 732–741. [CrossRef] [PubMed]
4. Zong, A.; Cao, H.; Wang, F. Anticancer polysaccharides from natural resources: A review of recent research.
Carbohydr. Polym. 2012, 90, 1395–1410. [CrossRef] [PubMed]
5. Colegate, S.M.; Molyneux, R.J. Bioactive Natural Products: Detection, Isolation, and Structural Determination;
CRC Press: Boca Raton, FL, USA, 2007.
6. Zhang, C.; Gao, Z.; Hu, C.; Zhang, J.; Sun, X.; Rong, C.; Jia, L. Antioxidant, antibacterial and anti-aging
activities of intracellular zinc polysaccharides from grifola frondosa sh-05. Int. J. Biol. Macromol. 2017, 95,
778–787. [CrossRef] [PubMed]
7. Sinha, V.; Kumria, R. Polysaccharides in colon-specific drug delivery. Int. J. Pharm. 2001, 224, 19–38.
[CrossRef]
8. Dong, B.; Hadinoto, K. Direct comparison between millifluidic and bulk-mixing platform in the synthesis of
amorphous drug-polysaccharide nanoparticle complex. Int. J. Pharm. 2017, 523, 42–51. [CrossRef]
Foods 2019, 8, 304 15 of 23

9. Jung, B.; Shim, M.-K.; Park, M.-J.; Jang, E.H.; Yoon, H.Y.; Kim, K.; Kim, J.-H. Hydrophobically modified
polysaccharide-based on polysialic acid nanoparticles as carriers for anticancer drugs. Int. J. Pharm. 2017,
520, 111–118. [CrossRef]
10. Nuti, E.; Santamaria, S.; Casalini, F.; Yamamoto, K.; Marinelli, L.; La Pietra, V.; Novellino, E.; Orlandini, E.;
Nencetti, S.; Marini, A.M. Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for
osteoarthritis: Synthesis and biological evaluation. Eur. J. Med. Chem. 2013, 62, 379–394. [CrossRef]
11. Chen, Q.; Mei, X.; Han, G.; Ling, P.; Guo, B.; Guo, Y.; Shao, H.; Wang, G.; Cui, Z.; Bai, Y. Xanthan gum protects
rabbit articular chondrocytes against sodium nitroprusside-induced apoptosis in vitro. Carbohydr. Polym.
2015, 131, 363–369. [CrossRef]
12. An, H.J.; Lebrilla, C.B. Structure elucidation of native n-and o-linked glycans by tandem mass spectrometry
(tutorial). Mass Spectrom. Rev. 2011, 30, 560–578. [CrossRef]
13. MaKi-Arvela, P.I.; Salmi, T.; Holmbom, B.; Willfor, S.; Murzin, D.Y. Synthesis of sugars by hydrolysis of
hemicelluloses-a review. Chem. Rev. 2011, 111, 5638–5666. [CrossRef] [PubMed]
14. Yang, L.; Zhang, L.-M. Chemical structural and chain conformational characterization of some bioactive
polysaccharides isolated from natural sources. Carbohydr. Polym. 2009, 76, 349–361. [CrossRef]
15. Xiao, Z.; Tappen, B.R.; Ly, M.; Zhao, W.; Canova, L.P.; Guan, H.; Linhardt, R.J. Heparin mapping using
heparin lyases and the generation of a novel low molecular weight heparin. J. Med. Chem. 2010, 54, 603–610.
[CrossRef]
16. Gatti, G.; Casu, B.; Hamer, G.; Perlin, A. Studies on the conformation of heparin by 1h and 13c nmr
spectroscopy. Macromolecules 1979, 12, 1001–1007. [CrossRef]
17. Varki, A.; Cummings, R.; Esko, J.; Stanley, P.; Hart, G.; Aebi, M.; Darvill, A.; Kinoshita, T.; Packer, N.;
Prestegard, J. Oligosaccharides and Polysaccharides—Essentials of Glycobiology, 3rd ed.; Cold Spring Harbor
Laboratory Press: Cold Spring Harbor, NY, USA, 2017.
18. Pool-Zobel, B.L. Inulin-type fructans and reduction in colon cancer risk: Review of experimental and human
data. Br. J. Nutr. 2005, 93, S73–S90. [CrossRef]
19. Chawla, R.; Patil, G. Soluble dietary fiber. Compr. Rev. Food Sci. Food Saf. 2010, 9, 178–196. [CrossRef]
20. Tungland, B.; Meyer, D. Nondigestible oligo-and polysaccharides (dietary fiber): Their physiology and role
in human health and food. Compr. Rev. Food Sci. Food Saf. 2002, 1, 90–109. [CrossRef]
21. Weng, L.-C.; Lee, N.-J.; Yeh, W.-T.; Ho, L.-T.; Pan, W.-H. Lower intake of magnesium and dietary fiber
increases the incidence of type 2 diabetes in taiwanese. J. Formos. Med. Assoc. 2012, 111, 651–659. [CrossRef]
22. Casiglia, E.; Tikhonoff, V.; Caffi, S.; Boschetti, G.; Grasselli, C.; Saugo, M.; Giordano, N.; Rapisarda, V.;
Spinella, P.; Palatini, P. High dietary fiber intake prevents stroke at a population level. Clin. Nutr. 2013, 32,
811–818. [CrossRef]
23. Viuda-Martos, M.; López-Marcos, M.; Fernández-López, J.; Sendra, E.; López-Vargas, J.; Pérez-Álvarez, J.
Role of fiber in cardiovascular diseases: A review. Food Sci. Food Saf. 2010, 9, 240–258. [CrossRef]
24. Whelton, S.P.; Hyre, A.D.; Pedersen, B.; Yi, Y.; Whelton, P.K.; He, J. Effect of dietary fiber intake on blood
pressure: A meta-analysis of randomized, controlled clinical trials. LWW 2005, 23, 475–481. [CrossRef]
25. Chau, C.-F.; Huang, Y.-L.; Lin, C.-Y. Investigation of the cholesterol-lowering action of insoluble fibre derived
from the peel of citrus sinensis l. Cv. Liucheng. Food Chem. 2004, 87, 361–366. [CrossRef]
26. Kendall, C.W.; Esfahani, A.; Jenkins, D.J. The link between dietary fibre and human health. Food Hydrocoll.
2010, 24, 42–48. [CrossRef]
27. Lunn, J.; Buttriss, J. Carbohydrates and dietary fibre. Nutr. Bull. 2007, 32, 21–64. [CrossRef]
28. Anderson, J.W.; Baird, P.; Davis, R.H.; Ferreri, S.; Knudtson, M.; Koraym, A.; Waters, V.; Williams, C.L. Health
benefits of dietary fiber. Nutr. Rev. 2009, 67, 188–205. [CrossRef]
29. Brown, L.; Rosner, B.; Willett, W.W.; Sacks, F.M. Cholesterol-lowering effects of dietary fiber: A meta-analysis.
Am. J. Clin. Nutr. 1999, 69, 30–42. [CrossRef]
30. Tang, W.; Hemm, I.; Bertram, B. Recent development of antitumor agents from chinese herbal medicines.
Part ii. High molecular compounds. Planta Med. 2003, 69, 193–201. [CrossRef]
31. Harlev, E.; Nevo, E.; Lansky, E.P.; Ofir, R.; Bishayee, A. Anticancer potential of aloes: Antioxidant,
antiproliferative, and immunostimulatory attributes. Planta Med. 2012, 78, 843–852. [CrossRef]
32. Thakur, M.; Weng, A.; Fuchs, H.; Sharma, V.; Bhargava, C.S.; Chauhan, N.S.; Dixit, V.K.; Bhargava, S.
Rasayana properties of ayurvedic herbs: Are polysaccharides a major contributor. Carbohydr. Polym. 2012,
87, 3–15. [CrossRef]
Foods 2019, 8, 304 16 of 23

33. Tian, L.; Zhao, Y.; Guo, C.; Yang, X. A comparative study on the antioxidant activities of an acidic
polysaccharide and various solvent extracts derived from herbal houttuynia cordata. Carbohydr. Polym. 2011,
83, 537–544. [CrossRef]
34. Jin, M.; Huang, Q.; Zhao, K.; Shang, P. Biological activities and potential health benefit effects of
polysaccharides isolated from lycium barbarum l. Int. J. Biol. Macromol. 2013, 54, 16–23. [CrossRef]
35. Li, T.; Peng, T. Traditional chinese herbal medicine as a source of molecules with antiviral activity. Antivir. Res.
2013, 97, 1–9. [CrossRef]
36. Harhaji, T.L.M.; Mijatović, S.A.; Maksimović-Ivanić, D.D.; Stojanović, I.D.; Momčilović, M.B.; Tufegdžić, S.J.;
Maksimović, V.M.; Marjanovi, Ž.S.; Stošić-Grujičić, S.D. Anticancer properties of ganoderma lucidum
methanol extracts in vitro and in vivo. Nutr. Cancer 2009, 61, 696–707. [CrossRef]
37. Ke, M.; Zhang, X.-J.; Han, Z.-H.; Yu, H.-Y.; Lin, Y.; Zhang, W.-G.; Sun, F.-H.; Wang, T.-J. Extraction, purification
of lycium barbarum polysaccharides and bioactivity of purified fraction. Carbohydr. Polym. 2011, 86, 136–141.
[CrossRef]
38. El Khoury, D.; Cuda, C.; Luhovyy, B.; Anderson, G. Beta glucan: Health benefits in obesity and metabolic
syndrome. J. Nutr. Metab. 2011, 2012. [CrossRef]
39. Zhang, W.; Xu, P.; Zhang, H. Pectin in cancer therapy: A review. Trends Food Sci. Technol. 2015, 44, 258–271.
[CrossRef]
40. Wijesekara, I.; Pangestuti, R.; Kim, S.-K. Biological activities and potential health benefits of sulfated
polysaccharides derived from marine algae. Carbohydr. Polym. 2011, 84, 14–21. [CrossRef]
41. Zhu, W.; Xue, X.; Zhang, Z. Structural, physicochemical, antioxidant and antitumor property of an acidic
polysaccharide from polygonum multiflorum. Int. J. Biol. Macromol. 2017, 96, 494–500. [CrossRef]
42. Agyemang, K.; Han, L.; Liu, E.; Zhang, Y.; Wang, T.; Gao, X. Recent advances in astragalus membranaceus
anti-diabetic research: Pharmacological effects of its phytochemical constituents. Evid.-Based Complement.
Altern. Med. 2013, 2013. [CrossRef]
43. Volpi, N. Anti-inflammatory activity of chondroitin sulphate: New functions from an old natural
macromolecule. Inflammopharmacology 2011, 19, 299–306. [CrossRef] [PubMed]
44. Behera, S.S.; Ray, R.C. Konjac glucomannan, a promising polysaccharide of amorphophallus konjac k. Koch
in health care. Int. J. Biol. Macromol. 2016, 92, 942–956. [CrossRef] [PubMed]
45. Loh, S.H.; Park, J.-Y.; Cho, E.H.; Nah, S.-Y.; Kang, Y.-S. Animal lectins: Potential receptors for ginseng
polysaccharides. J. Ginseng Res. 2017, 41, 1–9. [CrossRef] [PubMed]
46. Casu, B.; Naggi, A.; Torri, G. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein
interaction in inflammation and cancer. Matrix Biol. 2010, 29, 442–452. [CrossRef] [PubMed]
47. Xie, Y.; Zhang, B.; Zhang, Y. Protective effects of acanthopanax polysaccharides on cerebral ischemia–
reperfusion injury and its mechanisms. Int. J. Biol. Macromol. 2015, 72, 946–950. [CrossRef] [PubMed]
48. Kim, S.-K.; Li, Y.-X. Medicinal benefits of sulfated polysaccharides from sea vegetables. Adv. Food Nutr. Res.
2011, 64, 391–402. [PubMed]
49. Olafsdottir, E.S.; Ingólfsdottir, K. Polysaccharides from lichens: Structural characteristics and biological
activity. Planta Medica 2001, 67, 199–208. [CrossRef] [PubMed]
50. Chattopadhyay, N.; Ghosh, T.; Sinha, S.; Chattopadhyay, K.; Karmakar, P.; Ray, B. Polysaccharides from
turbinaria conoides: Structural features and antioxidant capacity. Food Chem. 2010, 118, 823–829. [CrossRef]
51. Schepetkin, I.A.; Quinn, M.T. Botanical polysaccharides: Macrophage immunomodulation and therapeutic
potential. Int. Immunopharmacol. 2006, 6, 317–333. [CrossRef] [PubMed]
52. Omarsdottir, S.; Freysdottir, J.; Olafsdottir, E.S. Immunomodulating polysaccharides from the lichen thamnolia
vermicularis var. Subuliformis. Phytomedicine 2007, 14, 179–184. [CrossRef]
53. Zambare, V.P.; Christopher, L.P. Biopharmaceutical potential of lichens. Pharm. Biol. 2012, 50, 778–798.
[CrossRef] [PubMed]
54. Martinichen-Herrero, J.; Carbonero, E.; Sassaki, G.; Gorin, P.; Iacomini, M. Anticoagulant and antithrombotic
activities of a chemically sulfated galactoglucomannan obtained from the lichen cladoniaibitipocae. Int. J.
Biol. Macromol. 2005, 35, 97–102. [CrossRef] [PubMed]
55. Ngo, D.-H.; Kim, S.-K. Sulfated polysaccharides as bioactive agents from marine algae. Int. J. Biol. Macromol.
2013, 62, 70–75. [CrossRef] [PubMed]
Foods 2019, 8, 304 17 of 23

56. Zhang, J.; Wen, C.; Duan, Y.; Zhang, H.; Ma, H. Advance in cordyceps militaris (linn) link polysaccharides:
Isolation, structure, and bioactivities: A review. Int. J. Biol. Macromol. 2019, 132, 906–914. [CrossRef]
[PubMed]
57. Meng, X.; Liang, H.; Luo, L. Antitumor polysaccharides from mushrooms: A review on the structural
characteristics, antitumor mechanisms and immunomodulating activities. Carbohydr. Res. 2016, 424, 30–41.
[CrossRef] [PubMed]
58. Yu, Y.; Shen, M.; Song, Q.; Xie, J. Biological activities and pharmaceutical applications of polysaccharide from
natural resources: A review. Carbohydr. Polym. 2018, 183, 91–101. [CrossRef] [PubMed]
59. Negre-Salvayre, A.; Coatrieux, C.; Ingueneau, C.; Salvayre, R. Advanced lipid peroxidation end products in
oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br. J.
Pharmacol. 2008, 153, 6–20. [CrossRef] [PubMed]
60. Kamerling, J.P.; Gerwig, G.J. Strategies for the structural analysis of carbohydrates. Compr. Glycosci. 2007,
1–68. [CrossRef]
61. Feng, F.; Zhou, Q.; Yang, Y.; Zhao, F.; Du, R.; Han, Y.; Xiao, H.; Zhou, Z. Characterization of highly branched
dextran produced by leuconostoc citreum b-2 from pineapple fermented product. Int. J. Biol. Macromol. 2018,
113, 45–50. [CrossRef]
62. Chen, L.; Ge, M.-D.; Zhu, Y.-J.; Song, Y.; Cheung, P.C.K.; Zhang, B.-B.; Liu, L.-M. Structure, bioactivity and
applications of natural hyperbranched polysaccharides. Carbohydr. Polym. 2019, 223, 115076. [CrossRef]
63. Cerning, J. Exocellular polysaccharides produced by lactic acid bacteria. FEMS Microbiol. Rev. 1990, 7,
113–130. [CrossRef] [PubMed]
64. Pereira, S.; Micheletti, E.; Zille, A.; Santos, A.; Moradas-Ferreira, P.; Tamagnini, P.; De Philippis, R. Using
extracellular polymeric substances (eps)-producing cyanobacteria for the bioremediation of heavy metals:
Do cations compete for the eps functional groups and also accumulate inside the cell? Microbiology 2011, 157,
451–458. [CrossRef] [PubMed]
65. Guezennec, J. Deep-sea hydrothermal vents: A new source of innovative bacterial exopolysaccharides of
biotechnological interest? J. Ind. Microbiol. Biotechnol. 2002, 29, 204–208. [CrossRef] [PubMed]
66. Senni, K.; Pereira, J.; Gueniche, F.; Delbarre-Ladrat, C.; Sinquin, C.; Ratiskol, J.; Godeau, G.; Fischer, A.-M.;
Helley, D.; Colliec-Jouault, S. Marine polysaccharides: A source of bioactive molecules for cell therapy and
tissue engineering. Mar. Drugs 2011, 9, 1664–1681. [CrossRef] [PubMed]
67. Roger, O.; Kervarec, N.; Ratiskol, J.; Colliec-Jouault, S.; Chevolot, L. Structural studies of the main
exopolysaccharide produced by the deep-sea bacterium alteromonas infernus. Carbohydr. Res. 2004, 339,
2371–2380. [CrossRef] [PubMed]
68. Zhou, Y.; Cui, Y.; Qu, X. Exopolysaccharides of lactic acid bacteria: Structure, bioactivity and associations:
A review. Carbohydr. Polym. 2019, 207, 317–332. [CrossRef] [PubMed]
69. Kay, E.; Cuccui, J.; Wren, B.W. Recent advances in the production of recombinant glycoconjugate vaccines.
NPJ Vaccines 2019, 4, 16. [CrossRef]
70. Gatenholm, P.; Tenkanen, M. Industrially Isolated Hemicellulose; ACS Symposium Series: Washington, DC,
USA, 2004; pp. 1–2.
71. Barsett, H.; Ebringerová, A.; Harding, S.; Heinze, T.; Hromádková, Z.; Muzzarelli, C.; Muzzraelli, R.;
Paulsen, B.; Elseoud, O. Polysaccharides I: Structure, Characterisation and Use; Springer Science & Business
Media: Berlin, Germany, 2005; Volume 186.
72. Ebringerová, A.; Hromádková, Z.; Hříbalová, V.; Xu, C.; Holmbom, B.; Sundberg, A.; Willför, S. Norway
spruce galactoglucomannans exhibiting immunomodulating and radical-scavenging activities. Int. J. Biol.
Macromol. 2008, 42, 1–5. [CrossRef]
73. Le Normand, M.; Mélida, H.; Holmbom, B.; Michaelsen, T.E.; Inngjerdingen, M.; Bulone, V.; Paulsen, B.S.;
Ek, M. Hot-water extracts from the inner bark of norway spruce with immunomodulating activities.
Carbohydr. Polym. 2014, 101, 699–704. [CrossRef]
74. Aachary, A.A.; Prapulla, S.G. Xylooligosaccharides (xos) as an emerging prebiotic: Microbial synthesis,
utilization, structural characterization, bioactive properties, and applications. Food Sci. Food Saf. 2011, 10,
2–16. [CrossRef]
75. Van Ophoven, A.; Vonde, K.; Koch, W.; Auerbach, G.; Maag, K.P. Efficacy of pentosan polysulfate for the
treatment of interstitial cystitis/bladder pain syndrome: Results of a systematic review of randomized
controlled trials. Curr. Med. Res. Opin. 2019, 1–9. [CrossRef] [PubMed]
Foods 2019, 8, 304 18 of 23

76. Li, J.; Mei, X. Applications of Cellulose and Cellulose Derivatives in Immediate Release Solid Dosage; ACS Publications:
Washington, DC, USA, 2006.
77. Chappell, E.P.; Liu, J. Use of biosynthetic enzymes in heparin and heparan sulfate synthesis. Bioorg. Med.
Chem. 2013, 21, 4786–4792. [CrossRef] [PubMed]
78. Linhardt, R.J. 2003 Claude S. Hudson award address in carbohydrate chemistry. Heparin: Structure and
activity. J. Med. Chem. 2003, 46, 2551–2564. [CrossRef] [PubMed]
79. Sakiyama-Elbert, S.E. Incorporation of heparin into biomaterials. Acta Biomater. 2014, 10, 1581–1587.
[CrossRef] [PubMed]
80. Schedin-Weiss, S.; Richard, B.; Hjelm, R.; Olson, S.T. Antiangiogenic forms of antithrombin specifically bind
to the anticoagulant heparin sequence. Biochemistry 2008, 47, 13610–13619. [CrossRef] [PubMed]
81. Rajangam, K.; Behanna, H.A.; Hui, M.J.; Han, X.; Hulvat, J.F.; Lomasney, J.W.; Stupp, S.I. Heparin binding
nanostructures to promote growth of blood vessels. Nano Lett. 2006, 6, 2086–2090. [CrossRef] [PubMed]
82. Zhang, F.; Walcott, B.; Zhou, D.; Gustchina, A.; Lasanajak, Y.; Smith, D.F.; Ferreira, R.S.; Correia, M.T.S.;
Paiva, P.M.; Bovin, N.V. Structural studies of the interaction of crataeva tapia bark protein with heparin and
other glycosaminoglycans. Biochemistry 2013, 52, 2148–2156. [CrossRef] [PubMed]
83. Silbert, J.E.; Sugumaran, G. Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life 2002, 54, 177–186.
[CrossRef]
84. Takegawa, Y.; Araki, K.; Fujitani, N.; Furukawa, J.-I.; Sugiyama, H.; Sakai, H.; Shinohara, Y. Simultaneous
analysis of heparan sulfate, chondroitin/dermatan sulfates, and hyaluronan disaccharides by glycoblotting-
assisted sample preparation followed by single-step zwitter-ionic-hydrophilic interaction chromatography.
Anayticall Chem. 2011, 83, 9443–9449. [CrossRef]
85. Sugahara, K.; Mikami, T.; Uyama, T.; Mizuguchi, S.; Nomura, K.; Kitagawa, H. Recent advances in the
structural biology of chondroitin sulfate and dermatan sulfate. Curr. Opin. Struct. Biol. 2003, 13, 612–620.
[CrossRef]
86. Kwok, J.; Warren, P.; Fawcett, J. Chondroitin sulfate: A key molecule in the brain matrix. Int. J. Biochem.
Cell Biol. 2012, 44, 582–586. [CrossRef]
87. Zou, X.; Foong, W.; Cao, T.; Bay, B.; Ouyang, H.; Yip, G. Chondroitin sulfate in palatal wound healing.
J. Dent. Res. 2004, 83, 880–885. [CrossRef]
88. Alliston, T. Chondroitin sulfate and growth factor signaling in the skeleton: Possible links to mps vi. J. Pediatr.
Rehabil. Med. 2010, 3, 129–138.
89. Balazs, E.A. Therapeutic use of hyaluronan. Struct. Chem. 2009, 20, 341–349. [CrossRef]
90. Gaffney, J.; Matou-Nasri, S.; Grau-Olivares, M.; Slevin, M. Therapeutic applications of hyaluronan.
Mol. BioSyst. 2010, 6, 437–443. [CrossRef]
91. Prestwich, G.D. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in
regenerative medicine. J. Control. Release 2011, 155, 193–199. [CrossRef]
92. Khan, F.; Ahmad, S.R. Polysaccharides and their derivatives for versatile tissue engineering application.
Macromol. Biosci. 2013, 13, 395–421. [CrossRef]
93. Logesh, A.; Thillaimaharani, K.; Sharmila, K.; Kalaiselvam, M.; Raffi, S. Production of chitosan from
endolichenic fungi isolated from mangrove environment and its antagonistic activity. Asian Pac. J.
Trop. Biomed. 2012, 2, 140–143. [CrossRef]
94. Khor, E.; Lim, L.Y. Implantable applications of chitin and chitosan. Biomaterials 2003, 24, 2339–2349. [CrossRef]
95. Rinaudo, M. Main properties and current applications of some polysaccharides as biomaterials. Polym. Int.
2008, 57, 397–430. [CrossRef]
96. Chao, Z.; Ri-Fu, Y.; Tai-Qiu, Q. Ultrasound-enhanced subcritical water extraction of polysaccharides from
lycium barbarum l. Sep. Purif. Technol. 2013, 120, 141–147. [CrossRef]
97. Song, T.; Pranovich, A.; Holmbom, B. Separation of polymeric galactoglucomannans from hot-water extract
of spruce wood. Bioresour. Technol. 2013, 130, 198–203. [CrossRef]
98. Cheng, H.; Feng, S.; Jia, X.; Li, Q.; Zhou, Y.; Ding, C. Structural characterization and antioxidant activities of
polysaccharides extracted from epimedium acuminatum. Carbohydr. Polym. 2013, 92, 63–68. [CrossRef]
99. Chen, S.; Chen, H.; Tian, J.; Wang, J.; Wang, Y.; Xing, L. Enzymolysis-ultrasonic assisted extraction, chemical
characteristics and bioactivities of polysaccharides from corn silk. Carbohydr. Polym. 2014, 101, 332–341.
[CrossRef]
Foods 2019, 8, 304 19 of 23

100. Abe, M.; Fukaya, Y.; Ohno, H. Extraction of polysaccharides from bran with phosphonate or phosphinate-
derived ionic liquids under short mixing time and low temperature. Green Chem. 2010, 12, 1274–1280.
[CrossRef]
101. Do Nascimento, D.M.; Dias, A.F.; De Araújo Junior, C.P.; De Freitas Rosa, M.; Morais, J.P.S.;
De Figueirêdo, M.C.B. A comprehensive approach for obtaining cellulose nanocrystal from coconut fiber.
Part II: Environmental assessment of technological pathways. Ind. Crops Prod. 2016, 93, 58–65. [CrossRef]
102. Matavire, T.O. Extraction and Modification of Hemicellulose from Wheat Bran to Produce Entrapment
Materials for the Controlled Release of Chemicals and Bioactive Substances. Master’s Thesis, Stellenbosch
University, Stellenbosch, South Africa, March 2018.
103. Boukroufa, M.; Boutekedjiret, C.; Petigny, L.; Rakotomanomana, N.; Chemat, F. Bio-refinery of orange peels
waste: A new concept based on integrated green and solvent free extraction processes using ultrasound and
microwave techniques to obtain essential oil, polyphenols and pectin. Ultrason. Sonochem. 2015, 24, 72–79.
[CrossRef]
104. Maheshwari, G.; Sowrirajan, S.; Joseph, B. Extraction and isolation of β-glucan from grain sources—A review.
J. Food Sci. 2017, 82, 1535–1545. [CrossRef]
105. Amid, B.T.; Mirhosseini, H. Optimisation of aqueous extraction of gum from durian (durio zibethinus) seed:
A potential, low cost source of hydrocolloid. Food Chem. 2012, 132, 1258–1268. [CrossRef]
106. Yanuriati, A.; Marseno, D.W.; Harmayani, E. Characteristics of glucomannan isolated from fresh tuber of
porang (amorphophallus muelleri blume). Carbohydr. Polym. 2017, 156, 56–63. [CrossRef]
107. Zhang, Y.; Zhang, Y.; Taha, A.A.; Ying, Y.; Li, X.; Chen, X.; Ma, C. Subcritical water extraction of bioactive
components from ginseng roots (panax ginseng ca mey). Ind. Crops Prod. 2018, 117, 118–127. [CrossRef]
108. Guo, Z.; Lou, Y.; Kong, M.; Luo, Q.; Liu, Z.; Wu, J. A systematic review of phytochemistry, pharmacology
and pharmacokinetics on astragali radix: Implications for astragali radix as a personalized medicine. Int. J.
Mol. Sci. 2019, 20, 1463. [CrossRef]
109. Zhu, W.; Xue, X.; Zhang, Z. Ultrasonic-assisted extraction, structure and antitumor activity of polysaccharide
from polygonum multiflorum. Int. J. Biol. Macromol. 2016, 91, 132–142. [CrossRef]
110. Lv, L.; Cheng, Y.; Zheng, T.; Li, X.; Zhai, R. Purification, antioxidant activity and antiglycation of
polysaccharides from polygonum multiflorum thunb. Carbohydr. Polym. 2014, 99, 765–773. [CrossRef]
111. Alves, A.; Caridade, S.G.; Mano, J.F.; Sousa, R.A.; Reis, R.L. Extraction and physico-chemical characterization
of a versatile biodegradable polysaccharide obtained from green algae. Carbohydr. Res. 2010, 345, 2194–2200.
[CrossRef]
112. Xu, S.-Y.; Huang, X.; Cheong, K.-L. Recent advances in marine algae polysaccharides: Isolation, structure,
and activities. Mar. Drugs 2017, 15, 388. [CrossRef]
113. Yu, X.; Zhou, C.; Yang, H.; Huang, X.; Ma, H.; Qin, X.; Hu, J. Effect of ultrasonic treatment on the degradation
and inhibition cancer cell lines of polysaccharides from porphyra yezoensis. Carbohydr. Polym. 2015, 117,
650–656. [CrossRef]
114. Tsubaki, S.; Oono, K.; Hiraoka, M.; Onda, A.; Mitani, T. Microwave-assisted hydrothermal extraction of
sulfated polysaccharides from ulva spp. and monostroma latissimum. Food Chem. 2016, 210, 311–316.
[CrossRef]
115. Lee, W.-W.; Ahn, G.; Wijesinghe, W.; Yang, X.; Ko, C.-I.; Kang, M.-C.; Lee, B.-J.; Jeon, Y.-J. Enzyme-assisted
extraction of ecklonia cava fermented with lactobacillus brevis and isolation of an anti-inflammatory
polysaccharide. Algae 2011, 26, 343–350. [CrossRef]
116. Rodriguez-Jasso, R.M.; Mussatto, S.I.; Pastrana, L.; Aguilar, C.N.; Teixeira, J.A. Microwave-assisted extraction
of sulfated polysaccharides (fucoidan) from brown seaweed. Carbohydr. Polym. 2011, 86, 1137–1144.
[CrossRef]
117. Murray, P.G.; Grassick, A.; Laffey, C.D.; Cuffe, M.M.; Higgins, T.; Savage, A.V.; Planas, A.; Tuohy, M.G.
Isolation and characterization of a thermostable endo-β-glucanase active on 1, 3-1, 4-β-d-glucans from the
aerobic fungus talaromyces emersonii cbs 814.70. Enzym. Microb. Technol. 2001, 29, 90–98. [CrossRef]
118. Nie, S.; Cui, S.W.; Xie, M.; Phillips, A.O.; Phillips, G.O. Bioactive polysaccharides from cordyceps sinensis:
Isolation, structure features and bioactivities. Bioact. Carbohydr. Diet. Fibre 2013, 1, 38–52. [CrossRef]
119. Klein, S. Polysaccharides in Oral Drug Delivery: Recent Applications and Future Perspectives; ACS Symposium
Series: Washington, DC, USA, 2009; pp. 13–30.
Foods 2019, 8, 304 20 of 23

120. Olano-Martin, E.; Gibson, G.R.; Rastall, R. Comparison of the in vitro bifidogenic properties of pectins and
pectic-oligosaccharides. J. Appl. Microbiol. 2002, 93, 505–511. [CrossRef]
121. Witvrouw, M.; De Clercq, E. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.
Gen. Pharmacol. Vasc. Syst. 1997, 29, 497–511. [CrossRef]
122. Nangia-Makker, P.; Hogan, V.; Honjo, Y.; Baccarini, S.; Tait, L.; Bresalier, R.; Raz, A. Inhibition of human
cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J.Natl. Cancer Inst.
2002, 94, 1854–1862. [CrossRef]
123. Lattimer, J.M.; Haub, M.D. Effects of dietary fiber and its components on metabolic health. Nutrients 2010, 2,
1266–1289. [CrossRef]
124. Georgiev, Y.; Ognyanov, M.; Yanakieva, I.; Kussovski, V.; Kratchanova, M. Isolation, characterization and
modification of citrus pectins. J. BioSci. Biotechnol. 2012, 1, 223–233.
125. Cheng, H.; Li, S.; Fan, Y.; Gao, X.; Hao, M.; Wang, J.; Zhang, X.; Tai, G.; Zhou, Y. Comparative studies of the
antiproliferative effects of ginseng polysaccharides on ht-29 human colon cancer cells. Med. Oncol. 2011, 28,
175–181. [CrossRef]
126. Jeon, C.; Kang, S.; Park, S.; Lim, K.; Hwang, K.W.; Min, H. T cell stimulatory effects of korean red ginseng
through modulation of myeloid-derived suppressor cells. J. Ginseng Res. 2011, 35, 462. [CrossRef]
127. Kim, M.-H.; Byon, Y.-Y.; Ko, E.-J.; Song, J.-Y.; Yun, Y.-S.; Shin, T.; Joo, H.-G. Immunomodulatory activity of
ginsan, a polysaccharide of panax ginseng, on dendritic cells. Korean J. Physiol. Pharmacol. 2009, 13, 169–173.
[CrossRef]
128. Kim, K.-H.; Lee, Y.-S.; Jung, I.-S.; Park, S.-Y.; Chung, H.-Y.; Lee, I.-R.; Yun, Y.-S. Acidic polysaccharide from
panax ginseng, ginsan, induces th1 cell and macrophage cytokines and generates lak cells in synergy with
ril-2. Planta Medica 1998, 64, 110–115. [CrossRef]
129. Lee, Y.; Chung, I.; Lee, I.; Kim, K.; Hong, W.; Yun, Y. Activation of multiple effector pathways of immune
system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from panax ginseng.
Anticancer Res. 1997, 17, 323–331.
130. Yoo, D.-G.; Kim, M.-C.; Park, M.-K.; Park, K.-M.; Quan, F.-S.; Song, J.-M.; Wee, J.J.; Wang, B.-Z.; Cho, Y.-K.;
Compans, R.W. Protective effect of ginseng polysaccharides on influenza viral infection. PLoS ONE 2012, 7,
e33678. [CrossRef]
131. Sun, Y. Structure and biological activities of the polysaccharides from the leaves, roots and fruits of panax
ginseng ca meyer: An overview. Carbohydr. Polym. 2011, 85, 490–499. [CrossRef]
132. Lemmon, H.R.; Sham, J.; Chau, L.A.; Madrenas, J. High molecular weight polysaccharides are key
immunomodulators in north american ginseng extracts: Characterization of the ginseng genetic signature in
primary human immune cells. J. Ethnopharmacol. 2012, 142, 1–13. [CrossRef]
133. Rigaud, D.; Ryttig, K.; Angel, L.; Apfelbaum, M. Overweight treated with energy restriction and a dietary
fibre supplement: A 6-month randomized, double-blind, placebo-controlled trial. Int. J. Obes. 1990, 14,
763–769.
134. Birketvedt, G.; Aaseth, J.; Florholmen, J.; Ryttig, K. Long-term effect of fibre supplement and reduced energy
intake on body weight and blood lipids in overweight subjects. Acta Medica (Hradec Kralove) 2000, 43, 129–132.
135. Pittler, M.H.; Ernst, E. Guar gum for body weight reduction: Meta-analysis of randomized trials. Am. J. Med.
2001, 110, 724–730. [CrossRef]
136. Mueller-Cunningham, W.M.; Quintana, R.; Kasim-Karakas, S.E. An ad libitum, very low-fat diet results
in weight loss and changes in nutrient intakes in postmenopausal women. J. Am. Diet. Assoc. 2003, 103,
1600–1606. [CrossRef]
137. Hays, N.P.; Starling, R.D.; Liu, X.; Sullivan, D.H.; Trappe, T.A.; Fluckey, J.D.; Evans, W.J. Effects of an ad
libitum low-fat, high-carbohydrate diet on body weight, body composition, and fat distribution in older men
and women: A randomized controlled trial. Arch. Int. Med. 2004, 164, 210–217. [CrossRef]
138. Howarth, N.C.; Saltzman, E.; Roberts, S.B. Dietary fiber and weight regulation. Nutr. Rev. 2001, 59, 129–139.
[CrossRef]
139. Birketvedt, G.S.; Shimshi, M.; Thom, E.; Florholmen, J. Experiences with three different fi ber supplements in
weight reduction. Med. Sci. Monit. 2005, 11, PI5–PI8.
140. Lyly, M.; Liukkonen, K.-H.; Salmenkallio-Marttila, M.; Karhunen, L.; Poutanen, K.; Lähteenmäki, L. Fibre in
beverages can enhance perceived satiety. Eur. J. Nutr. 2009, 48, 251–258. [CrossRef]
Foods 2019, 8, 304 21 of 23

141. Lyly, M.; Ohls, N.; Lähteenmäki, L.; Salmenkallio-Marttila, M.; Liukkonen, K.-H.; Karhunen, L.; Poutanen, K.
The effect of fibre amount, energy level and viscosity of beverages containing oat fibre supplement on
perceived satiety. Food Nutr. Res. 2010, 54, 2149. [CrossRef]
142. Vitaglione, P.; Lumaga, R.B.; Montagnese, C.; Messia, M.C.; Marconi, E.; Scalfi, L. Satiating effect of a barley
beta-glucan–enriched snack. J. Am. Coll. Nutr. 2010, 29, 113–121. [CrossRef]
143. Vitaglione, P.; Lumaga, R.B.; Stanzione, A.; Scalfi, L.; Fogliano, V. B-glucan-enriched bread reduces energy
intake and modifies plasma ghrelin and peptide yy concentrations in the short term. Appetite 2009, 53,
338–344. [CrossRef]
144. Peters, H.P.; Boers, H.M.; Haddeman, E.; Melnikov, S.M.; Qvyjt, F. No effect of added β-glucan or of
fructooligosaccharide on appetite or energy intake. Am. J. Clin. Nutr. 2008, 89, 58–63. [CrossRef]
145. Gallaher, D.D.; Gallaher, C.M.; Mahrt, G.J.; Carr, T.P.; Hollingshead, C.H.; Hesslink , R., Jr.; Wise, J.
A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol
excretion in overweight normocholesterolemic humans. J. Am. Col. Nutr. 2002, 21, 428–433. [CrossRef]
146. Chen, H.-L.; Sheu, W.H.-H.; Tai, T.-S.; Liaw, Y.-P.; Chen, Y.-C. Konjac supplement alleviated hypercholesterolemia
and hyperglycemia in type 2 diabetic subjects—A randomized double-blind trial. J. Am. Col. Nutr. 2003, 22,
36–42. [CrossRef]
147. Tappy, L.; Gügolz, E.; Würsch, P. Effects of breakfast cereals containing various amounts of β-glucan fibers
on plasma glucose and insulin responses in niddm subjects. Diabetes Care 1996, 19, 831–834. [CrossRef]
148. Tapola, N.; Karvonen, H.; Niskanen, L.; Mikola, M.; Sarkkinen, E. Glycemic responses of oat bran products
in type 2 diabetic patients. Nutr. Metab. Cardiovasc. Dis. 2005, 15, 255–261. [CrossRef]
149. Mäkeläinen, H.; Anttila, H.; Sihvonen, J.; Hietanen, R.; Tahvonen, R.; Salminen, E.; Mikola, M.;
Sontag-Strohm, T. The effect of β-glucan on the glycemic and insulin index. Eur. J. Clin. Nutr. 2007,
61, 779. [CrossRef]
150. Maki, K.; Galant, R.; Samuel, P.; Tesser, J.; Witchger, M.; Ribaya-Mercado, J.; Blumberg, J.; Geohas, J. Effects of
consuming foods containing oat β-glucan on blood pressure, carbohydrate metabolism and biomarkers of
oxidative stress in men and women with elevated blood pressure. Eur. J. Clin. Nutr. 2007, 61, 786. [CrossRef]
151. Hallfrisch, J.; Scholfield, D.J.; Behall, K.M. Diets containing soluble oat extracts improve glucose and insulin
responses of moderately hypercholesterolemic men and women. Am. J. Clin. Nutr. 1995, 61, 379–384.
[CrossRef]
152. Nazare, J.A.; Normand, S.; Oste Triantafyllou, A.; Brac De La Perrière, A.; Desage, M.; Laville, M. Modulation
of the postprandial phase by β-glucan in overweight subjects: Effects on glucose and insulin kinetics.
Mol. Nutr. Food Res. 2009, 53, 361–369. [CrossRef]
153. Battilana, P.; Ornstein, K.; Minehira, K.; Schwarz, J.; Acheson, K.; Schneiter, P.; Burri, J.; Jequier, E.; Tappy, L.
Mechanisms of action of β-glucan in postprandial glucose metabolism in healthy men. Eur. J. Clin. Nutr.
2001, 55, 327. [CrossRef]
154. Chen, H.-L.; Cheng, H.-C.; Liu, Y.-J.; Liu, S.-Y.; Wu, W.-T. Konjac acts as a natural laxative by increasing stool
bulk and improving colonic ecology in healthy adults. Nutrition 2006, 22, 1112–1119. [CrossRef]
155. Wang, L.; Yu, X.; Yang, X.; Li, Y.; Yao, Y.; Lui, E.M.K.; Ren, G. Structural and anti-inflammatory characterization
of a novel neutral polysaccharide from north american ginseng (panax quinquefolius). Int. J. Biol. Macromol.
2015, 74, 12–17. [CrossRef]
156. Zhao, H.; Zhang, W.; Xiao, C.; Lu, C.; Xu, S.; He, X.; Li, X.; Chen, S.; Yang, D.; Chan, A. Effect of ginseng
polysaccharide on tnf-alpha and ifn-gamma produced by enteric mucosal lymphocytes in collagen induced
arthritic rats. J. Med. Plant Res. 2011, 5, 1536–1542.
157. Pillai, R.; Lacy, P. Inhibition of neutrophil respiratory burst and degranulation responses by cvt-e002, the main
active ingredient in cold-fx. Allergy Asthma Clin. Immunol. 2011, 7, A31. [CrossRef]
158. Biondo, P.D.; Goruk, S.; Ruth, M.R.; O’connell, E.; Field, C.J. Effect of cvt-e002™(cold-fx® ) versus a
ginsenoside extract on systemic and gut-associated immune function. Int. Immunopharmacol. 2008, 8,
1134–1142. [CrossRef]
159. Wang, M.; Guilbert, L.J.; Li, J.; Wu, Y.; Pang, P.; Basu, T.K.; Shan, J.J. A proprietary extract from north american
ginseng (panax quinquefolium) enhances il-2 and ifn-γ productions in murine spleen cells induced by con-a.
Int. Immunopharmacol. 2004, 4, 311–315. [CrossRef]
Foods 2019, 8, 304 22 of 23

160. Wang, M.; Guilbert, L.J.; Ling, L.; Li, J.; Wu, Y.; Xu, S.; Pang, P.; Shan, J.J. Immunomodulating activity of
cvt-e002, a proprietary extract from north american ginseng (panax quinquefolium). J. Pharm. Pharmacol.
2001, 53, 1515–1523. [CrossRef]
161. Kim, K.-S.; Seo, E.-K.; Lee, Y.-C.; Lee, T.-K.; Cho, Y.-W.; Ezaki, O.; Kim, C.-H. Effect of dietary platycodon
grandiflorum on the improvement of insulin resistance in obese zucker rats. J. Nutr. Biochem. 2000, 11,
420–424. [CrossRef]
162. Han, S.B.; Park, S.H.; Lee, K.H.; Lee, C.W.; Lee, S.H.; Kim, H.C.; Kim, Y.S.; Lee, H.S.; Kim, H.M. Polysaccharide
isolated from the radix of platycodon grandiflorum selectively activates b cells and macrophages but not t
cells. Int. Immunopharmacol. 2001, 1, 1969–1978. [CrossRef]
163. Li, R.; Qiu, S.; Chen, H.; Wang, L. Immunomodulatory effects of astragalus polysaccharide in diabetic mice.
J. Chin. Integr. Med. 2008, 6, 166–170. [CrossRef]
164. Chen, W.; Li, Y.-M.; Yu, M.-H. Astragalus polysaccharides: An effective treatment for diabetes prevention in
nod mice. Exp. Clin. Endocrinol. Diabetes 2008, 116, 468–474. [CrossRef]
165. Chen, W.; Yu, M.; Li, Y. Effects of astragalus polysaccharides on ultrastructure and oxidation/apoptosis
related cytokines’ gene expression of non-obese diabetic mice’s islets. Available online: https://europepmc.
org/abstract/cba/636484 (accessed on 15 June 2019).
166. Xue, C.; Yu, G.; Hirata, T.; Terao, J.; Lin, H. Antioxidative activities of several marine polysaccharides
evaluated in a phosphatidylcholine-liposomal suspension and organic solvents. Biosci. Biotechnol. Biochem.
1998, 62, 206–209. [CrossRef]
167. Oliveira, J.T.; Reis, R. Polysaccharide-based materials for cartilage tissue engineering applications. J. Tissue
Eng. Regen. Med. 2011, 5, 421–436. [CrossRef]
168. Wan, A.C.; Tai, B.C. Chitin—a promising biomaterial for tissue engineering and stem cell technologies.
Biotechnol. Adv. 2013, 31, 1776–1785. [CrossRef]
169. Croisier, F.; Jérôme, C. Chitosan-based biomaterials for tissue engineering. Eur. Polymer J. 2013, 49, 780–792.
[CrossRef]
170. Lu, H.F.; Lim, S.-X.; Leong, M.F.; Narayanan, K.; Toh, R.P.; Gao, S.; Wan, A.C. Efficient neuronal differentiation
and maturation of human pluripotent stem cells encapsulated in 3d microfibrous scaffolds. Biomaterials 2012,
33, 9179–9187. [CrossRef]
171. Venkatesan, J.; Kim, S.-K. Chitosan composites for bone tissue engineering—An overview. Mar. Drugs 2010,
8, 2252–2266. [CrossRef]
172. Barud, H.d.S.; De Araújo Júnior, A.M.; Saska, S.; Mestieri, L.B.; Campos, J.A.D.B.; De Freitas, R.M.;
Ferreira, N.U.; Nascimento, A.P.; Miguel, F.G.; Vaz, M.M.d.O.L.L. Antimicrobial brazilian propolis (epp-af)
containing biocellulose membranes as promising biomaterial for skin wound healing. Evid.-Based Complement.
Altern. Med. 2013, 2013. [CrossRef]
173. Hrynyk, M.; Martins-Green, M.; Barron, A.E.; Neufeld, R.J. Alginate-peg sponge architecture and role in the
design of insulin release dressings. Biomacromolecules 2012, 13, 1478–1485. [CrossRef]
174. Anilkumar, T.; Muhamed, J.; Jose, A.; Jyothi, A.; Mohanan, P.; Krishnan, L.K. Advantages of hyaluronic acid
as a component of fibrin sheet for care of acute wound. Biologicals 2011, 39, 81–88. [CrossRef]
175. Liakos, I.; Rizzello, L.; Scurr, D.J.; Pompa, P.P.; Bayer, I.S.; Athanassiou, A. All-natural composite wound
dressing films of essential oils encapsulated in sodium alginate with antimicrobial properties. Int. J. Pharm.
2014, 463, 137–145. [CrossRef]
176. Gu, Z.; Xie, H.; Huang, C.; Li, L.; Yu, X. Preparation of chitosan/silk fibroin blending membrane fixed with
alginate dialdehyde for wound dressing. Int. J. Biol. Macromol. 2013, 58, 121–126. [CrossRef]
177. Singh, R.; Singh, D. Radiation synthesis of pvp/alginate hydrogel containing nanosilver as wound dressing.
J. Mate. Sci. Mater. Med. 2012, 23, 2649–2658. [CrossRef]
178. Anisha, B.; Biswas, R.; Chennazhi, K.; Jayakumar, R. Chitosan–hyaluronic acid/nano silver composite sponges
for drug resistant bacteria infected diabetic wounds. Int. J. Biol. Macromol. 2013, 62, 310–320. [CrossRef]
179. Mizrahy, S.; Peer, D. Polysaccharides as building blocks for nanotherapeutics. Chem. Soc. Rev. 2012, 41,
2623–2640. [CrossRef]
180. Alvarez-Lorenzo, C.; Blanco-Fernandez, B.; Puga, A.M.; Concheiro, A. Crosslinked ionic polysaccharides for
stimuli-sensitive drug delivery. Adv. Drug Deliv. Rev. 2013, 65, 1148–1171. [CrossRef]
181. Reddy, K.; Krishna Mohan, G.; Satla, S.; Gaikwad, S. Natural polysaccharides: Versatile excipients for
controlled drug delivery systems. Asian J. Pharm. Sci. 2011, 6, 275–286.
Foods 2019, 8, 304 23 of 23

182. Jain, A.K.; Söderlind, E.; Viridén, A.; Schug, B.; Abrahamsson, B.; Knopke, C.; Tajarobi, F.; Blume, H.;
Anschütz, M.; Welinder, A. The influence of hydroxypropyl methylcellulose (hpmc) molecular weight,
concentration and effect of food on in vivo erosion behavior of hpmc matrix tablets. J. Control. Release 2014,
187, 50–58. [CrossRef]
183. Plackett, D.V.; Letchford, K.; Jackson, J.K.; Burt, H.M. A review of nanocellulose as a novel vehicle for drug
delivery. Nord. Pulp. Pap. Res. J. 2014, 29, 105–118. [CrossRef]
184. Kolakovic, R.; Peltonen, L.; Laukkanen, A.; Hirvonen, J.; Laaksonen, T. Nanofibrillar cellulose films for
controlled drug delivery. Eur. J. Pharm. Biopharm. 2012, 82, 308–315. [CrossRef]
185. Shelke, N.B.; James, R.; Laurencin, C.T.; Kumbar, S.G. Polysaccharide biomaterials for drug delivery and
regenerative engineering. Polym. Adv. Technol. 2014, 25, 448–460. [CrossRef]
186. Ji, A.; Su, D.; Che, O.; Li, W.; Sun, L.; Zhang, Z.; Yang, B.; Xu, F. Functional gene silencing mediated by
chitosan/sirna nanocomplexes. Nanotechnology 2009, 20, 405103. [CrossRef]
187. Chen, M.-C.; Huang, S.-F.; Lai, K.-Y.; Ling, M.-H. Fully embeddable chitosan microneedles as a sustained
release depot for intradermal vaccination. Biomaterials 2013, 34, 3077–3086. [CrossRef]

© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).